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OCCUPATIONAL EXPOSURE TO ISOFLURANE ANESTHETIC GAS IN THE
RESEARCH ENVIRONMENT
Andrea Mulvenon, Ph.D.
University of Nebraska, 2015
Supervisor: Chandran Achutan, Ph.D.
This dissertation is a compilation of studies related to the halogenated anesthetic
gas isoflurane. Historically, halogenated anesthetic gases have been used in the health
care industry. In 1977 the National Institute for Occupational Safety and Health (NIOSH)
issued a recommended exposure limit (REL) of two parts per million (ppm) averaged
over one hour of exposure for halogenated anesthetic gases (NIOSH 1977). The
purpose of the standard was to protect healthcare workers from exposure to halothane,
methoxyflurane, and chloroform. However, isoflurane only became available after the
NIOSH REL was adopted. Therefore, the NIOSH REL is not directly applicable to
isoflurane. Moreover, use of isoflurane in healthcare has diminished over the years, and
it is now more widely used in medical research laboratories and veterinary clinics. The
purpose of this dissertation is to demonstrate the need for an updated occupational
exposure limit for isoflurane. Four studies were conducted toward the completion of this
goal; a systematic review of the literature to investigate human health effects associated
with occupational exposure to isoflurane, a case study of a high exposure to isoflurane
and its control, an assessment of occupational exposure of isoflurane to researchers,
and a comparison of the effectiveness of control methods in reducing isoflurane waste
anesthetic gas (WAG).
In the first study, we searched the PubMed and Embase databases were
searched for articles with data on health effects associated with occupational isoflurane
exposure. Thirteen studies were found during the search that fit the review criteria. Five
of the studies reported no adverse human health effects. Eight of the studies reported
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human health effects ranging from genetic mutations, changes in cellular function,
symptoms of acute exposure, and congenital anomalies in the offspring of exposed
women.
In the second study, we found that researchers working with isoflurane in a small
unventilated space had exposures close to 30 ppm over a short-time period (0.48 and
1.15 hours) for the main researcher. Other members of the group had exposures above
2 parts per million (ppm). An active scavenging ventilation control which reduced
isoflurane exposure by an average of 86%.
In the third study, we showed that isoflurane exposure to researchers at a
medical research institution was significantly associated with scavenging technique and
role of the investigator (p = 0.02 and 0.04, respectively). Researchers using passive
scavenging canisters were exposed to a mean concentration of 3.18 ppm (%CV = 123)
and researchers using active scavenging were exposed to a mean isoflurane
concentration of 0.83 ppm (% CV = 89). Researchers who performed the greater part of
the procedures were exposed to a mean of 2.71 ppm (%CV = 108) and researchers who
assisted were exposed to a mean of 1.18 ppm (%CV = 97).
In the final study, we evaluated isoflurane exposures when using active
scavengers, passive canister scavengers, and combinations of both scavenging
techniques. We also evaluated isoflurane exposures with no scavenging control.
Isoflurane concentration was significantly associated with control method (p < 0.0001).
Post hoc Tukey’s comparison showed the significant difference (p = 0.05) in isoflurane
concentration between no scavenging and active scavenging conditions, no scavenging
and combination active and passive scavenging conditions, and passive and active
scavenging conditions. There was no difference between no scavenging and passive
scavenging conditions or active scavenging and combination scavenging conditions. The
mean isoflurane concentration while using no scavenging controls was 10.23 ppm (%CV
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= 12), and was 10.35 ppm (%CV = 58) while using passive scavenging. Isoflurane
concentration using active scavenging was 1.43 ppm (%CV = 15) and 0.59 ppm (%CV =
46) while using the combination scavenging method.
Researchers who use passive scavenging methods are more likely to be at risk
for isoflurane exposure above 2 ppm. Researchers should use active scavenging to
control isoflurane WAG.
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CHAPTER 1
ISOFLURANE EXPOSURE IN THE RESEARCH SETTING: OVERVIEW OF THE
PROBLEM
Anesthetic gases are used to induce a state of unconsciousness in humans and
animals during healthcare procedures. Anesthetic gases are also used to conduct
research procedures. There are approximately 100,000 medical scientists in the U.S.
(U.S. Department of Labor, 2015) who are potentially exposed to anesthetic gas in the
workplace. There are also approximately 143,000 individuals in the veterinary field who
are also likely to be exposed (U.S. Department of Labor, 2015). Cubizolles et al. (1992)
reported that workers exposed to anesthetic gases report symptoms of nausea,
headache, slower reaction time, neuropsychological syndrome, difficulties with memory,
peripheral neurological disorders and fatigue. The National Institute for Occupational
Safety and Health (NIOSH), an institute within the U.S. Centers for Disease Control
(CDC) also cites irritability, difficulties with judgement and coordination as well as liver
and kidney disease (NIOSH, 2007).
Occupational exposure to nitrous oxide and other anesthetic gases have been
associated with adverse birth outcomes such as spontaneous abortion, low birth weight,
premature birth, and infertility (Cohen et al., 1971, Knill-Jones et al., 1972, Rosenberg et
al., 1973). Occupational exposure to anesthetic gas is mainly due to leakage from the
induction, maintenance, or recovery process. Anesthetic gas that is leaked to the
surrounding environment is referred to as waste anesthetic gas (WAG). Best practice
guidelines state that WAGs should be controlled using scavenging techniques to protect
employees (NIOSH, 2007). Scavenging is the collection and subsequent containment or
evacuation of WAGs. Two commons methods of scavenging WAGs are active
scavenging using vacuum exhaust lines and passive scavenging with canisters.
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Isoflurane is a halogenated anesthetic gas that was introduced in the 1980s, after
NIOSH had published a recommended exposure limit (REL) for halogenated anesthetic
gases. At the time of the REL publication there was limited health data available for
these gases. However, with the data available for halothane, a two parts per million
(ppm) limit was recommended for all halogenated ethers (NIOSH, 1977). The rationale
behind this limit was to recommend the lowest possible exposure, which was determined
by the lowest level that the analytical method was able to detect at the time. However, in
the absence of a standard that specifically took into account isoflurane, the NIOSH REL
for halogenated gases has been applied to isoflurane and the newer halogenated ethers
by researchers (Barberio et al., 2006, Barker et al., 1997, Franco et al., 1992,
Friembichler et al., 2011, Gardner, 1989, Hobbhahan et al., 1998, Hoerauf et al., 1996,
Säre et al., 2011, Smith et al., 2002, Taylor et al., 2009)
Acute exposure to isoflurane has been associated with central nervous system
toxicity. Symptoms include headache, nausea, dizziness, loss of consciousness,
asphyxia. Severe occupational overexposures to isoflurane may result in death (OSHA,
2006). Newer publications have documented possible pathways of central nervous
system (CNS) toxicity (Acharya et al., 2015, Dittmar et al., 2015, Joksovic et al., 2015,
Kim et al., 2014, Sun et al., 2014, Uchimoto et al., 2014, Xie et al., 2007).
Isoflurane exposure in humans has been linked to an increase of chromosomal
abnormalities and DNA mutations (Bilban et al., 2005, Costa Paes et al., 2014, Hoerauf
et al., 1999, Hoerauf et al., 1999). These changes could result in negative health
outcomes including cancer and adverse birth outcomes. The International Agency for
Research on Cancer (IARC) has not designated isoflurane as carcinogenic because of.
Inadequate evidence of carcinogenicity to humans and animals (IARC, 1998).
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Recent studies in animal and in vitro models have described biological
mechanisms that could potentially cause negative health effects in humans. Isoflurane is
metabolized in the liver by cytochrome P450 2E1 into trifluoroacetic acid and inorganic
fluoride (Kharash et al., 1999). Several studies have described neurological effects of
isoflurane in animals (Archaraya et al., 2015, Dittmar et al., 2015, Joksovic et al., 2015).
In a recent study, isoflurane exposure has been shown to cause reactive oxygen species
accumulation in cells that results in apoptosis (Sun et al., 2014).
There has been limited epidemiological data concerning the health effects of
isoflurane exposure to humans. Most of these studies have been concerned with
exposure to anesthetic gases as a class of chemicals (Bilban et al., 2005, Costa Paes et
al., 2014, Hoerauf et al., 1999, Hoerauf et al., 1999). As a result, there are only a few
studies that focus on isoflurane exposure. Furthermore, anesthetic gases do not have
the same mechanisms, so it is not appropriate to generalize. As an example, nitrous
oxide exposure has been better studied than the other anesthetic gases. Health effects
associated with nitrous oxide do not necessarily reflect those of isoflurane. Nitrous oxide
is structurally different from isoflurane and has different pathways in the body. Therefore,
studies with a mixed exposure of isoflurane and nitrous oxide may not give an accurate
picture of the health effects of isoflurane. Isoflurane is similar in structure to the other
halogenated anesthetic gases desflurane, enflurane, halothane, and sevoflurane
(Corbett, 1976, Baden et al., 1990, Barker et al., 1997).
As isoflurane is now primarily used by researchers and veterinarians working
with animals, occupational exposures may be higher among these workers than among
health care workers. Operating theatres are designed with ventilation controls
specifically to reduce WAGs and other possible air pollutants. Research and veterinary
setting may have less rigorous institutional policies to govern how isoflurane is used and
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controls in place to reduce WAGs. Researchers may have to work in rooms that have
not been designed for the use of anesthetic gases. This may result in high exposures to
isoflurane that could be potentially hazardous to the health of the researchers.
The purpose of this dissertation is to demonstrate the need for an updated
occupational exposure limit for isoflurane. This study has been designed to achieve this
objective and focusses primarily workers in the scientific research and development
services North American Industry Classification System (NAICS), 541700 (US
Department of Labor, 2014). This research may also benefit individuals working in the
veterinary services field, NAICS 541940 (Veterinary Services) (US Department of Labor,
2014). Four studies were conducted to achieve this objective. These studies are
presented in the following order: A systematic review of available literature was
conducted to determine what health effects are associated with occupational isoflurane
exposure (Chapter 2). The objective of the systematic review was to find health effects
and exposure data that could be used to suggest a safe exposure limit for isoflurane. It
was hypothesized that occupational isoflurane exposure is associated with adverse
human health outcomes.
We conducted an intervention study in research dentists using isoflurane for a
research protocol. We evaluated exposures before and after the installation of a
ventilation control. (Chapter 3). The purpose of the study was to reduce isoflurane
exposures through a ventilation control. Researchers were relying on passive
scavenging canisters, as opposed to active methods such as ventilation, to evacuate air,
vacuum scavenging lines or working in a biosafety cabinet. It was hypothesized that
employees were exposed to high concentrations of isoflurane and that an active
scavenging vacuum line could be used to reduce isoflurane exposure to the researchers.
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Due to the high exposure of isoflurane found in the study of dental researchers
(Chapter 3), we determined that more information was needed about how isoflurane was
used in the institution. An exposure assessment study of several researchers,
conducting a variety of procedures, in different locations in the institution was conducted
to determine how isoflurane is used at the medical research institution (Chapter 4). The
purpose of this study was to identify working conditions and work practices that were
associated with high levels of isoflurane exposure. It was hypothesized that scavenging
controls, role of the researcher during the procedures, species of animals used for the
procedure, and number of animals would be associated with isoflurane exposure to
researchers.
More data was needed to be able to justify isoflurane WAG controls methods to
researchers. A comparison of current, commonly used isoflurane controls were
compared to determine which controls most effectively reduce isoflurane WAG exposure
to workers. Isoflurane concentration in an experimental setting was measured using
three common isoflurane control techniques (Chapter 5). The purpose of the study was
to determine how well each technique controlled isoflurane WAG. These techniques
were activated charcoal canisters for the passive scavenging of isoflurane, a vacuum
exhaust line for active scavenging, and a combination of passive and active scavenging.
It was hypothesized that isoflurane concentration would be different while using different
WAG control methods. The secondary hypothesis was that isoflurane concentration
would be different while using different brands of the passive scavenging canisters.
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The combined studies present a full picture of isoflurane use from known health
effects to current occupational exposures and exposure control methods. The systematic
review revealed that occupational exposure to isoflurane may be associated with
changes in cell function and genetic damage. The exposure assessments of researchers
showed that researchers are at risk for high exposures to isoflurane WAG when
performing research procedures. Active scavenging methods were shown to more
effectively control WAG than passive scavenging methods in three of the studies
(Chapters 3—5).
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CHAPTER 2
HEALTH EFFECTS RELATED TO OCCUPATIONAL ISOFLURANE EXPOSURE:
A SYSTEMATIC REVIEW
ABSTRACT
Isoflurane is the most commonly used anesthetic gas in the veterinary and
research fields. Few studies concerning health outcomes associated with isoflurane
have been published, since its introduction in the 1980s. The objective of this review is
to determine what health outcomes are associated with occupational exposure to
isoflurane. PubMed and Embase databases were searched for all studies concerning
occupational exposure to isoflurane anesthetic gas. There were thirteen studies that met
all of the eligibility criteria. Eligibility requirements were studies conducted on human
subjects, in which the population had documented occupational exposure to isoflurane,
health effects information related to the exposure, and published in English.
Eight of the studies reported some kind of adverse health outcome associated
with occupational exposure to isoflurane. Five of the studies reported that isoflurane
exposure was not associated with the adverse health outcomes of interest. Health
outcomes varied from the cellular level to the individual level. Four of the studies found
differences in rates of genetic mutations. One study found an increase in congenital
abnormalities and one found an association with symptoms such as headache, nausea,
and dizziness. Isoflurane is associated with some adverse health outcomes, although
more data is needed to determine the mechanism behind these outcomes.

8
INTRODUCTION
Isoflurane is the most commonly used anesthetic gas in the veterinary and
animal research fields. There have been no regulations or exposure recommendations
published by either the Occupational Safety and Health Administration (OSHA) or the
National Institute for Occupational Safety and Health (NIOSH) specifically for isoflurane.
This may in part be due to the lack of health effects data available for isoflurane
exposure. Acute exposure effects of isoflurane exposure are known to be headache,
nausea, loss of consciousness, and other symptoms of central nervous system (CNS)
effects (Occupational Safety and Health Administration, 2006). However, health effects
associated with chronic exposures likely to be observed in occupational studies have not
been well documented. These data are necessary to develop occupational exposure
limits for isoflurane.
Most studies completed on isoflurane focus on exposures and control methods.
These studies have not included health symptom data of any kind. The studies with
isoflurane exposure data often use healthcare workers as the sole study population.
Isoflurane is commonly used in the veterinary and research fields, so the healthcare
population does not truly represent the current exposed population. Isoflurane exposure
due to use in humans is also likely to be considerably different from exposures due to
use in animals. This is attributable to many factors, including induction and maintenance
techniques, and equipment as well has differences in ventilation between hospital
operating theaters and veterinary and research procedure rooms.
NIOSH published a recommended exposure limit (REL) of two parts per million
(ppm) for a one hour time period for halogenated anesthetic gases in 1977 (NIOSH,
1977). The standard was developed with data from the anesthetic gases chloroform,
trichloroethylene, halothane, methoxyflurane, enflurane, and fluroxene. Most of these
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anesthetics are no longer in use today. Notably, the newer generation halogenated
anesthetic gases sevoflurane, desflurane, and isoflurane are not mentioned in the
standard. At the time the standard was written these drugs were not in use.
The NIOSH standard of two ppm should not be interpreted as a safe exposure
level. At the time the standard was developed, little health data was available for these
anesthetic agents. Therefore, NIOSH set the REL as low as possible, which was defined
by the reliability of the sampling methods available. Two ppm was the lowest reliable
concentration of the anesthetic gases that could be sampled using charcoal adsorption
and analyzed using gas chromatography. There have been many improvements in both
sampling and analysis techniques. The limit of detection (LOD) of the MIRAN sapphire
direct reading instrument is 0.03 ppm and the LOD of passive monitoring badges is 0.04
ppm. Therefore, if the spirit of the NIOSH REL were to be applied to isoflurane today the
standard would be 0.04 ppm or lower.
The NIOSH standard was also specifically determined with healthcare workers in
mind. It was not anticipated that halogenated gases would be used outside of the strictly
controlled healthcare environment. Today, halogenated gases are more likely to be used
in veterinary practices and research environments than in the healthcare setting.
Veterinarians and researchers may not have the same training for safe anesthetic gas
use that healthcare workers are provided.
The NIOSH standard is not only outdated because it lacks the inclusion of newer
halogenated anesthetic gases; it is also outdated in respect to the population using and
exposed to the gases and the exposure assessment tools to evaluate exposure. The
NIOSH REL needs to be updated. Health effects data concerning isoflurane and the
newer halogenated anesthetic gases are needed to develop a reasonable and justifiable
exposure limit.
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A systematic review of the literature was conducted to determine what health
effects are associated with occupational exposure to isoflurane. The search was limited
to studies with an occupationally exposed study population and a non-exposed control
group. All health effects and occupational settings were included.
METHODS
We conducted a computerized search of PubMed and Embase for all studies on
occupational environmental exposure to isoflurane or other anesthetic gases. A
combination of the following MeSH heading and keywords were used: “occupational
exposure” or “environmental exposure” and “isoflurane” or “anesthetic gases”. The
search was conducted in December of 2014 and again in June of 2015. A limit of human
studies was applied to the search. No language filters were used. The search strategy
was translated for the Embase search interface. The full PubMed search strategy can be
found in Appendix A and the Embase strategy in Appendix B.
Studies without a comparison to a control group, without isoflurane exposure
data or did not include isoflurane exposure data during data analysis were excluded.
Papers that were non-English publications were excluded. The remaining studies were
thoroughly reviewed and assigned a grade of low, medium, or high quality using the
Newcastle-Ottawa Scale for Observational studies. A point-scale was used to determine
quality. Categories were based on traditional grading scales. Studies that received less
than one half of the available points were graded as poor. Studies that received 50—
70% of the points were graded as medium quality, and studies that received 80—100%
of the points were graded as high quality. All studies were graded by two reviewers
(A.M., C.A.). Studies were reviewed and graded separately by each reviewer.
Differences in grades were discussed until the reviewers reached a consensus.
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RESULTS
A total of 453 unique records were found in PubMed and Embase. Of these, 361
were studies on anesthetic gases other than isoflurane and were excluded from the
study. Non-English publications concerning isoflurane exposure were also excluded
(n=24). Studies with isoflurane exposure data, but no health outcomes data were also
excluded from the study (n=52). This left 16 studies that had both isoflurane exposure
data and health effects data. Two of these studies had no comparison group and were
excluded. One study had exposure information on isoflurane but did not include these
data in the analysis of health effects. This study was excluded (Figure 2.1).
Of the remaining 13 studies, five reported no adverse health effects associated
with occupational exposure to isoflurane. These five studies included one cohort study
design (Shuhaiber et al., 2002) and four studies of cross-sectional design (Franco et al.,
1993, Krenzischek et al., 2002, Lucchini et al., 1997, Scapellato et al., 2011). The cohort
study was rated of low quality and one cross-sectional study was rated high quality and
three were rated as medium (Table 2.1).
Four studies reported a significant difference in genetic damage associated with
exposure to isoflurane. These studies reported changes in chromosomes and DNA
damage. All studies reporting genetic differences were cross-sectional. Two of the
studies were rated as medium (Bilban et al., 2005, Costa Paes et al., 2014) and two
were rated as high (Hoerauf et al., 1999, Hoerauf et al., 1999) (Table 2.1).
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Keywords = occupational exposure,
isoflurane, anesthetic gas

PubMed (383)

Embase (394)

777
Duplicate Records (324)
453
Studies on other anesthetic gases
(361)

Studies with no health effects
data (52)

Non English publications (24)
16
Isoflurane exposure data not part
of statistical analysis for health
effects (1)

No comparison group (2)

13

Figure 2.1: Study selection process for systematic review of health effects associated with
occupational exposure to isoflurane. Number of studies is indicated in parentheses.
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Four studies reported other adverse health effects. These included a range of
health outcomes from symptoms associated with acute isoflurane exposure (Hill et al.,
1998) to changes in biomarkers (Franco et al., 1992) and cell functions (Goto et al.,
2000). One study found that isoflurane exposure was associated with an increase in
congenital anomalies in offspring of female veterinarians who were occupationally
exposed to isoflurane (Teschke et al., 2011). One of these studies was a cohort study
rated as medium in quality; the other three studies were cross-sectional and ranged in
quality from low to high (Table 2.1).
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Table 2.1: Summary of Studies Included in Review
Grade
(points)
Medium
(7)

Author Year
Bilban, M., et
al., 2005

Title
Cytogenetic tests
performed on operating
room personnel (the use of
anesthetic gases)

Study Design
Cross-sectional
Study population: Health care workers,
women (Subjects 153 Controls 197
and 153)
Statistical analysis: Pearson
correlation coefficient

Findings
Occupational exposure to a mixture of nitrous oxide,
isoflurane, and halothane anesthetic gases was
associated with and increased frequency of structural
chromosomal aberrations (p<0.001), sister chromatid
exchanges ( p<0.001), and increased number of
micronuclei (p<0.001).

Costa Paes,
R., et al., 2014

DNA damage and
antioxidant status in
medical residents
occupationally exposed to
waste anesthetic gases

Cross-sectional
Study population: Health care workers
(Subjects 15, Controls 15)
Statistical analysis: Student’s t test

Occupational exposure to isoflurane and other anesthetic
gases was associated with an increase in lymphocyte
DNA damage (p=0.001), and altered antioxidant
protection (p>0.001).

Medium
(7)

Franco G., et
al., 1992

Occupational exposure of
operating-theater personnel
to isoflurane and nitrous
oxide

Occupational exposure to isoflurane and nitrous oxide
was associated with an increase of urinary D-glucaric acid
(p<0.001).

High (8)

Franco, G., et
al., 1993

Drinking habits and
occupational exposure to
inhalation anesthetics at
low doses

Cross-sectional
Study population: Health care workers
(Subjects 24, Controls 24)
Statistical analysis: Student’s t test,
Chi square
Cross-sectional
Study population: Health care workers
(Subjects 80, Controls 92)
Statistical analysis: ANOVA

Occupational exposure to isoflurane and nitrous oxide
does not cause changes in serum aminotransferases ALT
and AST or mean corpuscular volume (MCV) of red blood
cells (p>0.05).

Medium
(7)

Goto, Y., et al.,
2000

Does chronic occupational
exposure to volatile
anesthetic agents influence
the rate of neutrophil
apoptosis?

Cross-sectional
Study population: Health care workers
(Subjects 20, Controls 10)
Statistical analysis: Student’s t test

Neutrophil apoptosis was inhibited by occupational
exposure to nitrous oxide, sevoflurane, and isoflurane
(p=0.008).

Low (4)

Hill, D., et al.,
1998

Occupational injuries and
illnesses reported by zoo
veterinarians in the United
States

Cross-sectional
Study population: Zoo veterinarians
(Subjects 277)
Statistical analysis: Chi square

Ten percent US zoo veterinarians reported adverse health
effects related to anesthetic gas exposure; isoflurane was
the anesthetic gas for 78.6% of the adverse reactions).
Female veterinarians were more likely to report an
adverse exposure to anesthetic gas (p=0.04).

Medium
(5)
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Hoerauf, K., et
al., 1999

Genetic damage in
operating room personnel
exposed to isoflurane and
nitrous oxide

Hoerauf, K., et
al., 1999

Waste anaesthetic gases
induce sister chromatid
exchanges in lymphocytes
of operating room
personnel

Krenzischek,
D., et al., 2002

Phase I collaborative pilot
study: Waste anesthetic
gas levels in the PACU

Lucchini, R., et
al., 1997

Neurobehavioral functions
in operating theatre
personnel: a multicenter
study

Scapellato, M.,
et al., 2001

Occupational exposure to
anaesthetic gases and
urinary excretion of Dglucaric acid

Shuhaiber, S.,
et al., 2002

A prospective-controlled
study of pregnant
veterinary staff exposed to
inhaled anesthetics and xrays

Teschke, K., et
al., 2011

Exposure to anesthetic
gases and congenital
anomalies in offspring of
female registered nurses

Cross-sectional
Study population: Health care workers
(Subjects 10, Controls 10)
Statistical analysis: Paired Student’s t
test
Cross-sectional
Study population: Health care workers
(Subjects 27, Controls 27)
Statistical analysis: Student’s t test

Exposure to nitrous oxide and isoflurane leads to an
increased frequency of sister chromatid exchanges
(p=0.036).

High (8)

Simultaneous exposure to isoflurane and nitrous oxide is
associated with increased frequency of sister chromatid
exchanges (p<0.05).

High (8)

Cross-sectional
Study population: Health care workers
(Subjects 6, Controls 3)
Statistical analysis: Student’s t test
Cross-sectional
Study population: Health care workers
(Subjects 112, Controls 135)
Statistical analysis: Student’s t test

Halogenated anesthetic gases are not associated with
adverse health symptoms (p=0.48).

Medium
(7)

Trace levels of nitrous oxide and isoflurane exposures are
not associated with neurobehavioral functions such as
stress and arousal. Exposure to anesthetic gases was not
associated with decrease or self-reported quality of life.

High (8)

Cross-sectional
Study population: Health care workers
(Subjects 229, Controls 229)
Statistical analysis: stepwise multiple
regression
Cohort
Study population: Veterinary staff,
women (Subjects 95, Controls 95)
Statistical analysis: Fisher’s exact or
Chi square

Exposure to the anesthetic gases isoflurane and nitrous
oxide is not associated with urinary D-glucaric acid (OR
0.68).

Medium
(7)

Occupational exposure to isoflurane and halothane
anesthetic gases is not associated with low birth weight
(p=0.06) or major malformations (p=0.96).

Low (4)

Cohort
Study population: Registered nurses,
women (Subjects 56,213)
Statistical analysis: binary
unconditional logistic regression model

Congenital anomalies are associated with “ever” and
“probable” exposure to halogenated anesthetic gases (OR
1.49, OR=2.61) and nitrous oxide (OR=1.42, OR=1.82).

Medium
(6)

Table 2.1: An overview of articles included in the systematic review. Studies were assigned points based on the Newcastle-Ottawa
Scale for observational studies. The listed scores reflect quality of the study and were based on the following point system: Low (1—
4 points), Medium (5—7 points), and High (8—10 points).
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DISCUSSION
Most of the studies included in this review were cross-sectional studies, which
would have allowed easy comparison between studies if the outcomes of the studies
had been similar. However, a variety of health outcomes were reported. The most
frequently studied health outcomes of isoflurane exposure in humans were related to
genetic damage. This includes studies focusing on singular aspects of genetic damage
including chromosome abnormalities, DNA damage, and sister chromatid exchanges.
Changes in cell function and other biomarkers were also studied. Most of these studies
were not associated with symptoms that employees could report as the outcomes are on
the cellular or sub-cellular level. These outcomes were also associated with low levels of
isoflurane exposure as demonstrated by the exposure assessment data in many of the
studies.
Four of the included studies contained self-reported health outcomes by
employees and with occupational exposure to isoflurane. Of these, only one study
focused on symptoms known to be associated with isoflurane anesthetic gas use such
as headache, nausea, and dizziness. This study relied on the participants to disclose
workplace exposures and did not estimate the exposures (Hill et al., 1998). As such, we
cannot determine if isoflurane is associated with these symptoms in a dose-dependent
manner. This information would be most helpful in establishing exposure limit
recommendations for isoflurane.
A limitation of this review is that most of the studies included had a mixed
exposure of isoflurane with other anesthetic gases. The most common mixture of gases
was nitrous oxide with isoflurane. A few studies also reported exposures to other
halogenated anesthetic gases. Health outcomes reported in these studies may result
from exposure from the other anesthetic gases, isoflurane, or the combination of
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exposure to isoflurane with other anesthetic gases. These studies were mostly
conducted with healthcare workers as the participants. Isoflurane is no longer commonly
used in this setting. However, veterinarians and researchers almost exclusively use
isoflurane for anesthesia. More epidemiological studies focused on veterinarians and
researchers could be beneficial in determining what health effects are associated with
isoflurane and at what concentrations. A strength of this review is that only observational
studies with control comparison groups were included.
A case study of three healthcare workers showed that in these cases exposure to
isoflurane and sevoflurane was associated with asthmatic symptoms and itchy rash
(Vellore et al., 2006). Symptoms in the three healthcare workers abated once they were
transferred to duties not associated with isoflurane and sevoflurane exposure. Cope
reported that exposure to isoflurane depressed central neurorespiratory activity in
healthcare workers (Cope et al., 2002). Long term effects of chronic exposure to
isoflurane have not been well documented or investigated. Studies in animal and cell
models have reported a number of health effects. Corbett noted that isoflurane and other
halogenated anesthetic ethers are similar in structure to human carcinogens bis
(chloromethyl) ether and chloromethyl methyl ether (Corbett, 1976). He went on to
investigate the possible mutagenic properties in mice and found that male offspring of
pregnant mice exposed to isoflurane at certain times during pregnancy went on to
develop hepatic neoplasms. The offspring were exposed to isoflurane during gestation
and after birth (Corbett, 1976). Four studies in this review reported genetic and DNA
damage was associated with isoflurane exposure. It is not outside the realm of possibility
that isoflurane could be a potential carcinogen.
A study in rats found that isoflurane negatively impacts short term cognitive
function. Uchimoto et al. found that isoflurane exposure impaired hippocampal learning
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in the exposed rats (Uchimoto et al., 2014). Cellular studies have found that isoflurane
exposure can induce apoptosis in cells (Xie et al., 2007) and accumulation of reactive
oxygen species (ROS) in cells (Sun et al., 2014). These studies indicate that isoflurane
is toxic at the cellular level which may translate to human toxicity.
Nitrous oxide and other anesthetic gases have been associated with adverse
birth outcomes such as spontaneous abortion, low birth weight, premature birth, and
infertility (Cohen et al., 1971, Knill-Jones et al., 1972, Rosenberg et al., 1973). One study
included in this review found an association between halogenated anesthetic gases and
nitrous oxide and congenital abnormalities in the offspring of exposed female
veterinarians (Tescheke et al., 2011). Again, the genetic and DNA damage reported in
other studies could be linked to this outcome. More studies with isoflurane as the only
exposure are needed to determine if isoflurane is associated with adverse birth
outcomes in humans.
This systematic review was unable to find the necessary health effects data to
recommend a safe exposure limit for isoflurane. Many of the studies were conducted
with study populations with a mixed exposure of anesthetic gases and populations in the
healthcare field. If researchers turned to study populations working in the veterinary and
research fields, a more homogenous picture of health effects associated with isoflurane
may be obtained. However, until those studies become available, no exposure limits can
be determined based on health effects. In the meantime, following the NIOSH REL of a
cumulative maximum of two ppm for one hour is the best plan of action.
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CONCLUSION
Isoflurane in combination with other anesthetic gases is associated with a variety
of potential health outcomes. These are related to more obvious symptoms such as
headache, nausea, and dizziness as well as to less noticeable outcomes such as
increased rates of DNA and genetic damage. No dose-dependent data was available for
these outcomes. We can only recommend that isoflurane exposure is kept to a
minimum. The NIOSH REL of two ppm cannot be determined as protective or nonprotective at this time.
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CHAPTER 3
EVALUATION AND CONTROL OF ISOFLURANE DURING EXPERIMENTAL DENTAL
PROCEDURES ON RODENTS
ABSTRACT
The purpose of this study was to assess exposures to isoflurane to employees
performing an experimental dental procedure on rodents. Isoflurane was used as an
anesthetic for rodents during injections and placement of dental apparatus into the
mouth. We collected eight full-shift samples using passive badges over a 3-week period.
Results showed that employees were being exposed to isoflurane above the National
Institute for Occupational Safety and Health recommended exposure level for
halogenated anesthetic gases of two parts per million. The procedure was performed
once a week for approximately 45 minutes each day. The employer installed a
ventilation system in the procedure room after the initial sampling and results. We
collected twelve full-shift samples after the ventilation system was in place. Results
showed an approximate 86% decrease in isoflurane concentration.
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INTRODUCTION
Exposure to waste anesthetic gas (WAG) in occupational settings has been
found to significantly increase the risk of miscarriage and infertility (Cohen et al., 1971,
Cohen et al., 1974, Knill-Jones et al., 1972, Rosenberg et al., 1973). The approximate
increased relative risk of miscarriage is 1.3—1.9 (Sessler et al., 1998). Several
epidemiological studies have found an increased risk of spontaneous abortion in
occupationally exposed women and the female partners of occupationally exposed men
(Knill-Jones et al., 1975, Tomlin, 1979, Cohen et al., 1980, Guirguis et al., 1990).
Chronic exposure to halogenated gases is also significantly correlated with an increased
risk of infertility in both men and women. Metabolites of halogenated gases accumulate
in the body and can then be exhaled in substantial amounts resulting in a secondary
exposure of others (Smith et al., 2005). Aside from reproductive toxicity, volatile
anesthetic gases are also associated with increased risks of hepatic and renal diseases
as well as psychological impairments among workers (NIOSH, 1977). The National
Institute for Occupational Safety and Health (NIOSH) recommended exposure level
(REL) for halogenated anesthetics states that exposure levels should not exceed two
parts per million (ppm) for any given task or time (NIOSH, 1977).
Isoflurane is a halogenated anesthetic gas and today it is one of the most
commonly used inhalation anesthetics for experimental and veterinary animal
procedures (Säre et al., 2011). Isoflurane has not been consistently linked with
reproductive toxicity in human studies. However, cellular studies have found that
isoflurane exposure inhibits mitochondrial function that may lead to increased reactive
oxygen species (ROS) levels. ROS have been found to be toxic to many cellular
functions. Uchimoto et al. showed that isoflurane induced anesthesia was associated
with learning deficits and young adult rats (Uchimoto et al., 2014). There is no
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Occupational Safety and Health Administration (OSHA) permissible exposure level
(PEL) for isoflurane; in addition, the NIOSH REL does not directly apply to isoflurane as
it was developed before isoflurane became available. Use of inhalation anesthetics can
result in the pollution of anesthetic gas in the workplace and resulting exposure to
employees. In animal procedures, an anesthetic state is often induced and maintained
using a face mask or nose cone. Several studies have already documented that using
face masks to induce anesthesia in humans results in a significant increase of WAG
concentrations that may exceed occupational exposure limits (Weber, 1994, Schuyt et
al., 1996, Hoerauf et al., 1997, Hoerauf et al., 1999). Using a scavenging mask or double
masking have been shown to reduce occupational exposure during human procedures.
Scavenging masks for rodents are also commercially available, but the efficacy of these
masks has not been sufficiently proven.
Appropriate engineering controls such as ventilation can be used to effectively
control WAGs. Surgical procedure rooms used for human procedures are often designed
and regulated to protect employees from high concentrations of WAGs. In contrast,
animal researchers must often utilize spaces for surgical procedures that have not been
designed for anesthetic gas use. The use of these spaces may lead to high exposures of
WAG to researchers. The purpose of this study was to investigate an isoflurane
exposure to animal researchers and the effectiveness of an engineered ventilation
control.
METHODS
In this intervention study, we measured study participants’ exposure to isoflurane
before and after the installation of an engineering control. Samples were collected using
passive badges (Advanced Chemical Sensors Inc., Boca Raton, FL). The badges were
placed in the breathing zone of the study participants. We collected three full-shift
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samples from a single researcher over a three-week period. We then collected eight fullshift personal samples from five dental researchers (the entire research group) over a
two-week period. Samples were collected once a week identical to how often the
researchers performed the procedure. This study was conducted as part of institutional
safety requirements and with approval of the University of Nebraska Medical Center
institutional review board.
Room ventilation conditions were 12.21 air changes per hour. Intake air was
filtered with a high-efficiency particulate absorption (HEPA) filter, and the room was kept
under positive pressure. The procedure room was small (area =106 ft2 or 32.31 m2,
volume = 848 ft3 or 24.0 m3).
An engineering control was designed and installed in the procedure room after
the initial sampling periods. After the installation, eleven full-shift personal samples for
isoflurane were collected from four employees over a three-week period. Samples were
collected once a week while researchers performed the research procedure. Job titles
and duties of the employees are listed in Table 3.1.
TABLE 3.1: Description of Study Participants and Duties
Study Participant Job Title
Gender Duties
Employee 1
Technician
Female Anesthetize and monitor animals
Employee 2
Dental Resident
Female Conduct procedure
Employee 3
Visiting Surgeon
Female Observe
Employee 4
Advising Professor Male
Assist
Employee 5
Dental Surgeon
Male
Assist
Process Description
The technician placed the animal in an induction chamber to induce anesthesia.
Isoflurane was introduced into the chamber at a concentration of 3% isoflurane and flow
rate of 1 liter per minutes (L/min) using an isoflurane vaporizer. The technician then
placed the animal on the surgical field so that the animal's nose was inside of a nosecone. The technician then manipulated the vaporizer, so that 1.5% isoflurane flowed to
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the nose cone at a rate of 1 L/min. The technician held the animal in place for the
duration of the procedure. F/Air activated charcoal canisters were used to scavenge
waste isoflurane gas. One canister was connected to each anesthesia station, the
induction chamber and the nose-cone.
Employee two, the lead researcher, injected the animal's gums on each side of
the mouth. Employees four and five assisted with the correct placement of the injections
by manipulating the animal's head, mouth, and tongue. Employee three observed the
procedure. After the injections had been completed, the researchers placed an
experimental dental apparatus in the mouths of the animals in the treatment group. The
animals recovered in a separate room. Control animals did not receive the dental
apparatus and recovered immediately after the injections.
Installation of Engineering Control
The institution had an engineering control designed and installed to remove
isoflurane WAG from the procedure room. This engineering control consisted of two
vacuum scavenging lines attached from the building exhaust to the procedure room. The
exhaust vented outside of the building away from any windows and air intake units. The
engineered control included a flow meter/ ball valve and 1 ½ inch modular hose for both
the induction chamber and the procedure table. The modular hose for the induction
chamber was fitted with a tapered oval anti-static nozzle. The modular hose for the
procedure table could me maneuvered into position by the researchers for optimal
scavenging and ease of use (Figure 3.3). Modular hoses were designed to be stored
attached to exhaust line and on the wall for easy access. The total cost of the system
was approximately $2,000.
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RESULTS AND DISCUSSION
Isoflurane Exposure Levels Pre-Installation of Engineering Control
We hypothesized that the technician would be at the highest risk for isoflurane
exposure due to the responsibility of handling the rodents and the isoflurane. The
technician's exposure to isoflurane was monitored during three sampling periods prior to
monitoring the entire research team. Isoflurane concentration was at or above the two
ppm REL for each of these three sampling periods. Exposure time ranged from 0.75 to
3.27 hours (Table 3.2).

TABLE 3.2: Isoflurane Exposure to Employee 1 (Technician).
Day
1
2
3

Isoflurane Concentration (ppm)
11.00
11.30
2.00

Time (hrs.)
3.27
1.50
0.75

The entire research team was monitored for isoflurane exposure during two
subsequent experimental procedures. Interestingly, the exposure levels of the other
researchers exceeded that of the technician. Employee two, the dental resident and lead
researcher, had the highest isoflurane exposure at 28.40 ppm over 0.48 hours and 29.30
ppm over 1.15 hours. The exposure most likely resulted from isoflurane leaking from the
nose-cone while the researcher leaned over the rodent while conducting the procedure
(Figure 3.1). The technician wore a powered air purifying respirator (PAPR) due to
previously identified allergy to animal dander. It is possible that the measurement of the
technician’s isoflurane exposure was impacted by air turbulence caused by air flow from
the bottom of the PAPR mask (Figure 3.1).
Employees three, four, and five were each monitored for one sampling period.
During the experimental procedures employees four and five assisted and also leaned
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over the animal. The source of the isoflurane exposure was likely the nose-cone.
Isoflurane exposure for employee four was 17.20 ppm over a 0.47 hours sampling
period and exposure for employee five was 13.20 ppm over 1.03 hours, both were well
above the NIOSH REL. Employee three observed the procedure, standing further from
the surgical field than the other employees. Isoflurane exposure was 7.90 ppm over 0.47
hours (Figure 3.2). The isoflurane concentration was below the limit of detection for all
field blank, and laboratory blank samples indicating the isoflurane exposures found for
the study participants resulted from the use of isoflurane as an anesthetic during their
investigations. The dental surgeons wore gloves and surgical masks. However, surgical
masks do not protect workers from isoflurane and other WAGs. It should also be noted
that the procedure did not take place in a fume hood or under any form of visible
ventilation.
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Figure 3.1: A) Researchers conducting procedure. Note that the researchers lean in over the
animal. B) Procedure was conducting on the mouth.
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Isoflurane Exposure to Employees Before Ventilation
Controls
35.00
29.30

28.40

30.00
25.00
20.00

17.20
13.20

15.00
10.00

7.70

7.90
3.10

5.00

NIOSH REL

0.00
Sampling Period 1

Employee 1

Employee 2

Employee 3

Sampling Period 2
Employee 4

Employee 5

FIGURE 3.2: Isoflurane exposure for study participants before installation of ventilation
control. Note that isoflurane concentration for employee two is well over ten times the
NIOSH REL of 2 ppm.
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Isoflurane Exposures Post-Installation of Engineering Control
After installation of the engineering control, the average isoflurane exposure
decreased approximately 86% from 10.96 ppm in 1.17 hours to 1.57 ppm in 1.43 hours.
The first sampling period after the scavenging unit was installed, the mean isoflurane
exposure for employees one, two four, and five was 2.52 ppm in 2.04 hours. While the
mean isoflurane exposure is above the two ppm NIOSH REL, employees one and five,
are below the REL while employees two and four are at four ppm. It should be noted that
during this sampling period, adjustments to the isoflurane apparatus had to be made
which could have led to an increase in the exposure levels. These adjustments were due
to the process of exchanging the oxygen tank, which was used to supply the carrier gas.
These adjustments are common, but not part of a daily use routine. The adjustments
increased the amount of time the researchers spent performing the procedure. The
second sampling period after the installation of the engineering control, the mean
isoflurane exposure was 0.46 ppm, which was a decrease of approximately 97% (Figure
3.4).
During the third sampling period after the installation of the engineering control,
the researchers made minor adjustments to the procedure table scavenging unit and the
nose-cone. A thinner hose was coupled to the larger hose of the scavenging unit to allow
the hose to be nearer the procedure without being in the way of the researchers. During
the prior experimental procedures, it was observed that the large hose of the scavenging
unit was bulky and at times hard for the researchers to work around. The opening of the
nose-cone was wrapped in clear tape, and then a smaller hole was cut to allow for the
rodents nose to enter the cone. This adjustment was meant to decrease the amount of
isoflurane gas that escaped from the nose cone by making a more snug fit around the
animal’s nose.
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The researchers placed the thinner hose, used to modify the engineering control,
directly next to the nose -cone. The researchers were able to work efficiently around the
thinner hose while still remaining close to the nose-cone. The average isoflurane
exposure during the procedure using these modifications was 2.13 ppm, slightly above
the NIOSH REL. This was an approximate 81% decrease compared to the sampling
periods before the engineering control was installed. Employees four and two had the
highest isoflurane concentration at 2.70 ppm and 2.40 ppm, respectively (Table 3.3).

TABLE 3.3: Comparison of Isoflurane Exposure Before and After Installation of
Ventilation Control
Date
Description
Mean (%CV), ppm
Range
10/5/2011
Pre-Engineering Control
15.3 (64.0)
7.7—28.4
10/12/2011 Pre-Engineering Control
15.2 (86.9)
3.1—29.3
1/25/2012
Implementation of Ventilation Control
1/25/2012
Post-Engineering Control
2.1 (81.5)
0.6—4.0
2/1/2012
Post-Engineering Control
0.5 (57.6)
0.3—0.8
2/8/2012
Post-Engineering Control
2.1 (34.6)
1.3—2.7
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Figure 3.3: Researchers using ventilation control during procedure. A) Vacuum
scavenging line placed on the procedure table to scavenging from the nose-cone. B)
Vacuum scavenging line placed near the induction chamber.
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35.00

Isoflurane Exposure to Employees With Ventilation
Controls

30.00
25.00
20.00
15.00
10.00
4.00
5.00

0.69

4.00
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0.28
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0.84
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2.40
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FIGURE 3.4: Isoflurane exposure to employees after installation of active ventilation
controls. The ventilation controls dramatically reduced isoflurane exposure. Note that all
employee exposures are under or near the NIOSH REL of 2 ppm.
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Installation of the engineering control reduced isoflurane concentration a
maximum of 97% (29.3 ppm to 0.84 ppm) close to the NIOSH REL of two ppm. The
mean reduction in isoflurane exposure was approximately 85%. The engineering control
removed isoflurane vapors from the procedure room most efficiently without the
attachment of the smaller hose. Researchers continued to use F/Air canisters during
procedures in conjunction with the engineering control.
A strength of this study was that the same procedure was conducted in the same
room by the same researchers both before and after the use of a ventilation control.
Researchers also had clear roles that did not change through the different sampling
periods. A limitation of the study was that not all researchers participated in each of the
procedures periods that were sampled.
CONCLUSIONS
In conclusion, employees were exposed to isoflurane concentrations well above
the NIOSH REL for halogenated anesthetic gases while using passive scavenging
techniques to control isoflurane vapors. Our initial hypothesis that the employee
responsible for anesthetizing and handling the animals would have the highest isoflurane
exposure was incorrect. The highest concentrations of isoflurane were experienced by
researchers bending over the anesthetized animal to perform the research procedure.
The lowest isoflurane exposure was experienced by the technician anesthetizing the
animals. WAG leaking from the nose-cone was likely to have contributed the most to the
exposure. Our results demonstrate the importance of considering all sources of
isoflurane waste anesthetic gas. An engineering control of additional ventilation
effectively reduced isoflurane concentration in the room. The isoflurane exposure was
reduced a maximum of 97% and a mean of 86%.
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CHAPTER 4
ASSESSMENT OF ISOFLURANE EXPOSURE
TO RESEARCHERS DURING ANIMAL PROCEDURES

ABSTRACT
Isoflurane is a commonly used anesthetic gas in veterinary and animal research
procedures. Symptoms of acute exposure to isoflurane include headache, nausea,
dizziness, unconsciousness, and asphyxia. However, isoflurane exposure to medical
researchers has not been well documented. We conducted a study of research
procedures using isoflurane at a medical research institution. Full-shift isoflurane
exposures to researchers were monitored using passive badges for halogenated
anesthetic vapors. Exposures ranged from 0.04 parts per million (ppm) to 9.6 ppm for a
15-minute time period. Species of animal used during the procedure, number of animals,
and procedure time were not found to be significant factors associated with isoflurane
exposure. Waste anesthetic gas (WAG) control method was found to be a significant
factor. Active scavenging methods such as biosafety cabinets and exhaust vacuum lines
were significantly more effective in controlling isoflurane WAG than passive scavenging
canisters. The role of the researcher was also a significant factor. Researchers who
were involved in anesthesia induction and performed the majority of the animal
procedure had higher isoflurane exposures than researchers who assisted during the
procedure.
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INTRODUCTION
Isoflurane is a core anesthetic on the World Health Organization’s (WHO) list of
essential medicines published in April 2013 (WHO, 2013). It is the preferred anesthetic
technique for most animal research and veterinary procedures today (Säre et al., 2011).
In the 1980s several studies showed that individuals using isoflurane on animals were at
risk for high exposures. Studies also indicated associations between waste anesthetic
gas exposure (WAG) and several adverse health effects including reproductive toxicity,
organ toxicity, and central nervous system toxicity (Cohen et al., 1980, Guirguis et al.,
1990, Spence et al., 1978). The lack of epidemiological data focused on isoflurane WAG
exposure has led to confusion concerning the potential long-term health risks caused by
occupational isoflurane exposure. The limited knowledge of health outcomes associated
with chronic isoflurane exposure is particularly troubling due to the ubiquitous use of
isoflurane in research and veterinary practice.
Although isoflurane is widely used, there has been little progress towards any
occupational exposure guidelines in the United States. In 1977, the National Institute of
Occupational Safety and Health (NIOSH) published a recommended exposure limit
(REL) of two parts per million (ppm) for halogenated anesthetic gases (NIOSH, 1977).
This standard was actually developed with the anesthetic gas halothane involved.
Isoflurane was not included in the REL as it had not been developed for use at that time.
NIOSH has not updated the halogenated gas REL or published an REL for isoflurane.
Exposure to isoflurane in animal research settings has not been well
characterized. Possible reasons may be the large-scale use of isoflurane use and the
unsupported belief that isoflurane is harmless. Inconsistency in research surgical
spaces, procedures performed, and species involved in procedures may also contribute
to the difficulty of characterizing isoflurane exposure to animal researchers. Many
species of animals are utilized in research, and there are different anesthesia techniques
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for induction and maintenance based on species of animal. Anesthesia methods may
also differ between research protocols. However, isoflurane is widely used to maintain
anesthesia during most animal surgical procedures including those performed in
veterinary settings.
Use of inhalation anesthetics can result in the pollution of anesthetic gas in the
workplace resulting in exposure to employees. In large animal procedures, an anesthetic
state is often induced by using a face mask and maintained by intubation. Induction
chambers and nose cones are used in small animal procedures. Several studies have
already documented that using face masks to induce anesthesia in humans results in a
significant increase of WAG concentrations that may exceed limit values (Hoerauf et al.,
1997, Hoerauf et al., 1999, Schuyt et al., 1996, Weber, 1994).
The goal of this study was to measure researchers’ isoflurane exposure during
animal procedures and to observe and document work practices of researchers during
isoflurane use. WAG control methods, species of animals used during the procedure,
and roles of the investigators were compared to determine which variables were more
likely to contribute to isoflurane exposure.
METHODS
Study Population
Participants were identified by the institution’s Comparative Medicine
department. All researchers at the institution using isoflurane during the time of the study
were eligible to participate. A total of 33 laboratories were identified as owning isoflurane
vaporizers, which are devices used to deliver isoflurane for anesthesia. An additional
seven laboratories were identified as scheduling procedures using an isoflurane
vaporizer with the Comparative Medicine department. Forty letters were sent to the
principle investigator (PI) or contact person on record for the laboratories requesting
researchers to participate in isoflurane monitoring by contacting the study investigators.
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A total of thirty-six (90%) replies were received. Of these, twenty of the researchers
replied that they were not using isoflurane at this time, the remaining respondents
agreed to participate in the study and scheduled a time to be monitored for isoflurane
exposure. Four researchers who did not reply were contacted a second time.
A total of 23 different research procedures and thirty-nine individual researchers
from 16 different laboratories were included in the study. The study participants included
five PIs, twenty-one research technicians, and thirteen junior researchers including
graduate students and post-docs. All participants were sampled while using isoflurane to
anesthetize animals during research procedures. No interventions were used during this
study. Employees were asked to perform work tasks as usual, including all safety and
controls methods normally used. The study was conducted between November 2014
and June 2015. This study was conducted as part of institutional safety requirements
and with the approval of the University of Nebraska Medical Center institutional review
board.
Isoflurane Sampling
Full-shift personal air samples were collected using halogenated anesthetic
vapor passive badges purchased from Advanced Chemical Sensors (Boca Raton, FL).
Sampling medium in the badges was activated carbon molecular sieve adsorbent. The
limit of quantification for the badges was 0.04 ppm for an 8-hour period. The limit of
detection for isoflurane was 0.01 ppm for 15 minutes (Advanced Chemical Sensors).
One field blank was collected per procedure for quality control and comparison
purposes.
The badges were clipped to the collars of lab coats of personnel to represent
exposures in their personal breathing zone. Work practices of study participants,
procedure descriptions, and scavenging techniques for waste anesthetic gas were
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recorded during isoflurane use. The passive badges were analyzed per OSHA method
103 (OSHA, 1994) by Advanced Chemical Sensors.
Statistical Analysis
Differences in isoflurane exposure between researchers working on large or
small animal species and scavenging type were analyzed using Mann-Whitney analysis
for nonparametric analysis. Large animals were defined as animals that were intubated
to maintain anesthesia (pig and rabbit). Small animals species were defined as animals
that anesthesia was induced inside an induction chamber and maintained using a nosecone. Scavenging techniques were categorized as active or passive. Active scavenging
was defined as the use of a biological safety cabinet (BSC) or fume hood, and the use of
an exhaust line to evacuate isoflurane WAG. Passive scavenging was defined as the
use of an activated charcoal canister specifically marketed to control WAG. Only one
researcher per procedure was included in the study. Procedures that were repeated by
the same researchers were only included once in the study analysis. Samples were
chosen based on representativeness of the personal exposure to the individual. A twosided p-value ˂ 0.05 was considered significant.
Isoflurane exposure was compared between primary and secondary researchers
using the Wilcoxon signed rank test. Researchers were divided into two groups: primary
or secondary. The primary researcher was defined as the individual who performed the
bulk of the procedure including the induction and maintenance of anesthesia. Secondary
researchers were defined as individuals who assisted in the procedure and were not
responsible for the greater amount of work involved with the animal procedure. Only
procedures in which at least two or more researchers were involved were included in the
analysis. Two researchers per group were used in the analysis. Procedures performed
by the same research group were only included once. A p-value ˂ 0.05 was considered
significant.
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Differences in isoflurane concentration and the length of time of procedures and
the number of animals used in the procedures were analyzed using Spearman
correlation statistics. Only researchers who worked with mice were included in this
analysis as this was the only species with enough data to conduct the analysis. One
researcher per procedure was included in the analysis. There were no repeated
procedures included in the analysis. A p-value ˂ 0.05 was considered significant. Full
data set is presented in Appendix C.
RESULTS
Procedure Descriptions
Researchers used isoflurane for several procedures. Table 4.1 summarizes the
procedures observed for the study. Detailed descriptions of these procedures are
provided in Appendix D. Studies included non-survival and survival procedures in pigs,
rats, and mice. A single survival study was conducted using rabbits. Non-survival studies
included studies that used isoflurane for anesthesia maintenance during a procedure
followed by dissection and protocols that used isoflurane as a euthanasia technique.
Survival studies included surgical implantation of monitoring devices, imaging, injection
delivery, and outcomes of new treatments.
Anesthesia induction and maintenance varied by species of animals used in the
procedure. Large animals such as pigs and rabbits were intubated to maintain
anesthesia. Anesthesia was induced in pigs using a face-mask. Anesthesia was induced
in the rabbit using an injectable anesthetic. Anesthesia was induced in small animals,
such as rats and mice, using an induction chamber. Both the open-drop method of using
an isoflurane soaked material in an air tight container and isoflurane vaporizer
connected to an induction chamber were observed. Protocols that required anesthesia to
be maintained for the entire procedure used a nose-cone to keep the animal under
sedation.
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Several locations were used to conduct the research procedures. The controls
available varied by room. Most procedure rooms in the Comparative Medicine facility
housed either a biosafety cabinet (BSC) or vacuum exhaust line or both. Researchers
working outside of this facility did not always have access to these WAG scavenging
controls. If no BSC or vacuum exhaust line was available the researchers relied on
passive scavenging canisters to control isoflurane vapors.
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Table 4.1: Overview of Monitored Procedures

Procedure Description
Cardiac Arrest
Treatment
Cardiac Arrest
Treatment
Cardiac Arrest
Treatment
Cardiac Arrest
Treatment
Surgical Robot Test
Acute Cardiac Disease
Model
Cardiac Arrest
Treatment
Intraperitoneal
Injections
*Liver Cancer Model
Telemeter Implantation
#
Body Composition
#
Body Composition
Dissection
Dissection
Dissection
Drug Pump
Implantation
Embryo Transfer
Surgery
Heart Ultrasound
#
Humanized Liver
Model
Kidney Ultrasound
MRI

Number of
Researchers
Monitored

Scavenging
Method

Animal
Species

Number
of
Animals

2

Passive

Pig

1

2

Passive

Pig

1

2

Passive

Pig

1

3
5

Passive
Active

Pig
Pig

2
1

1

Passive

Rabbit

1

4

Active

Rat

1

2
3
1
1
1
1
1
4

Passive
Passive
Passive
Active
Active
Active
Active
Passive

Rat
Rat
Rat
Mouse
Mouse
Mouse
Mouse
Mouse

12
4
3
23
15
10
3
4

1

Passive

Mouse

3

2
2

Active
Passive

Mouse
Mouse

6
6

2
1
2

Active
Passive
Active

Mouse
Mouse
Mouse

4
8
1

Skin Disease Model
1
Active
Mouse
20
Time Course Model
2
Active
Mouse
5
*Researchers used active scavenging during anesthesia induction and
passive scavenging during procedure.
#
Researchers used passive scavenging during induction and active
scavenging during procedure.
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Active vs. Passive Scavenging Techniques
Four active scavenging techniques were observed during the study. They
included active vacuum lines, vacuum lines used with passive scavenging canisters,
BSC, and BSC used with canisters (Figure 4.1). Researchers who used BSCs with
passive canisters were classified as using active scavenging (Table 4.2). Differences in
mean isoflurane concentrations between the active scavenging techniques were not
calculated due to the small sample size.

Table 4.2 : Active Scavenging Technique Used During Procedures
Scavenging Technique
n
Isoflurane Exposure (ppm)
Mean (% CV), ppm
BSC
2
0.28, 0.64
0.46 (55)
BSC + Canister
5
0.12, 0.25, 0.42, 0.53, 0.56
0.38 (50)
Vacuum Line
2
0.61, 3.6
2.1 (100)
Vacuum Line + Canister
1
1.3
0.12, 0.25, 0.28, 0.42, 0.53, 0.56,
Total
10
0.61 0.64, 3.6, 1.3
0.83 (123)

Isoflurane exposure for researchers using active scavenging was statistically
lower than for researchers who relied on passive scavenging canisters as the only way
to control isoflurane WAG (p = 0.02) (Table 4.3). A typical surgical procedure area setup
using passive scavenging and active scavenging are shown in Figure 4.2 A-B.

Table 4.3: Isoflurane Exposure by Scavenging Technique
Scavenging Technique
n
Mean (%CV), ppm
Range, ppm
Active
10 0.83 (123)
0.12—3.60
Passive
10 3.18 (89)
0.09—9.50
Isoflurane exposure was lower for researchers using active
scavenging compared to researchers using passive scavenging,
Mann-Whitney, p = 0.02.
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Figure 4.1: Combination of passive and active scavenging controls. Researcher used
passive scavenging for induction and BSC for active scavenging during the procedure.
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Figure 4.2: Typical setup for small animal surgery. A) Passive scavenging canister is
used to control WAG. B) Vacuum lime is used to control WAG.
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Large vs. Small Animals Species
Large animals such as the pigs and rabbits were intubated to maintain
anesthesia while rats and mice were placed on nose cones to maintain anesthesia.
Isoflurane exposure to researchers was not statistically different between researchers
working with large animals or small animals (p = 0.08) (Table 4.4).

Table 4.4: Isoflurane Exposure by Species
Species
n
Mean (%CV), ppm
Range, ppm
Small
17
2.07 (122)
0.12—9.5
Large
3
1.66 (107)
0.09—3.6
Isoflurane exposure did not differ by animal species, p = 0.08.
Isoflurane Concentration by Researcher Role
The overall mean isoflurane exposure to researchers was 1.95 ppm.
Researchers who had the largest roles during the procedures had higher mean
exposure to isoflurane (2.71 ppm) compared to researchers who had secondary or
assisting roles (1.18 ppm). This was a statistically significant difference in isoflurane
exposure (p = 0.04). A total of 22 researchers (11 pairs) were included in the analysis
(Table 4.5).

Table 4.5: Isoflurane Exposure by Role
Role
n
Mean (%CV), ppm
Range, ppm
Primary
11 2.71 (108)
0.25—9.50
Secondary
11 1.18 (97)
0.15—3.70
Isoflurane exposure was higher for researchers who had the
primary role in the procedure versus researchers who were
assisting, p = 0.04.
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Isoflurane Concentration by Procedure Time and Number of Animals
Isoflurane concentration for researchers working with mice was not correlated
with the length of the procedure (p = 0.26). The number of animals used during the
procedure was also not correlated with isoflurane exposure to researchers (p = 0.20). A
total of 13 samples were included in the analysis.
DISCUSSION
Approximately 31% (12/39) of the researchers included in the study had
isoflurane exposures above the NIOSH REL of two ppm for halogenated anesthetic
gases; so by current practice standards we can state that 31% of the participants were
over-exposed to isoflurane vapors.
We used passive sampling badges that adsorb isoflurane to monitor for
isoflurane exposure. Some research groups have monitored isoflurane exposure by
using biomarkers to determine actual isoflurane concentration in the body (Accorsi et al.,
2001, Al-Chanem et al., 2008, Imbriani et al., 1988). These studies found that ambient
air levels of isoflurane were correlated to urinary isoflurane concentration. Periago et al.,
(1993), reported that isoflurane concentration in the exhaled breath of exposed
individuals was also correlated to ambient isoflurane concentration.
While these sampling methods have the benefit of quantifying isoflurane load in
the body, they require biological samples. Biological samples are generally more difficult
to obtain and have higher costs associated with storage, shipping, and analysis. Due to
these constraints, biological monitoring of isoflurane has not been used to monitor
isoflurane exposure in the field.
Other sampling methods for isoflurane include active sampling methods.
Personal pumps which draw air into a charcoal tube can be used to more accurately
quantify exposure. However, the pumps are more susceptible to human error, as they
can be accidently turned off during the monitoring period or develop mechanical
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difficulties. Real-time exposure monitoring instruments have been developed that can be
used to measure isoflurane concentration in the air. These units are associated with a
high initial cost and are usually not justifiable in most occupational settings. We chose to
use passive monitoring badges as they are the most cost efficient, easy to use, and the
most used method to monitor for isoflurane concentration.
Procedures being conducted at a single research institution can vary widely. We
sampled nineteen different procedures using four different species of animals. Research
was conducted in several different rooms and four different building on the same
campus. Air exchanges in the different rooms and buildings may impact isoflurane
concentration. Older buildings may have less efficient exhaust which would increase
isoflurane concentration in the room. However, due to the equipment required for the
procedure and familiarity of laboratory spaces, researchers may be disinclined to work in
newer rooms specifically designed with a high number of air exchanges. Scavenging
capabilities may also be impacted by the procedure room. Some of the procedures took
place in rooms that had a BSC or vacuum exhaust line available, while other rooms had
no means of active scavenging.
As many research procedures as possible were included in the study. However,
the sample size was too small to fully investigate all of the different variables. Isoflurane
concentration and flow rate were too variable to be compared in the small sample size.
However, these factors have the potential to influence individual isoflurane exposure.
This study was also not able to evaluate the effectiveness of different active scavenging
methods. It would be interesting to compare BSCs and vented fume hoods to vacuum
exhaust lines to determine if they are equally efficient in removing isoflurane vapors. We
were not able to compare researchers’ work practices, such as latching an induction
chamber closed vs. keeping the latch open, or concentration and flow rate of isoflurane
used during the procedures. We would also be interested in conducting a study to
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examine different nose-cones in rodents to determine how nose-cones may impact
isoflurane exposure. Future studies with a larger number of participants could compare
some of these factors.
There are several individual work practices that can be implemented to reduce
exposure to isoflurane. An example of simple behavior is ensuring that induction
chambers are closed and air-tight during use. Personnel can also decrease their
exposure by performing tasks that do not require isoflurane before the procedure, thus
reducing exposure time. These work practices can be taught but are difficult to enforce
at an institutional level.
Environmental controls, however, are controls that institutions can regulate to
reduce isoflurane exposure to many users. Rooms in which isoflurane are used should
have an appropriate number of air changes and ventilation. NIOSH recommends 15 air
changes per hour for clinical operating theatres (NIOSH, 2007). Recommended
ventilation for laboratories is 4 to 12 air changes per hour (OSHA, 1990). Active
scavenging methods should be used whenever possible. Active scavenging methods
can be as simple as using a ventilated hood or biosafety cabinet. OSHA recommends
that researchers use ventilated fume hoods whenever possible when working with
hazardous or potentially hazardous chemicals (OSHA, 2011). Institutions may also
provide vacuum lines attached to the building exhaust to remove isoflurane efficiently
from procedure areas. Passive scavenging techniques using activated charcoal
canisters are not enough to keep exposures below the two ppm NIOSH REL for
halogenated anesthetic vapors.
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CONCLUSION
Active scavenging techniques significantly reduce isoflurane exposure to animal
researchers. Researchers who used only passive scavenging canisters had a mean
isoflurane exposure twice as high as researchers who used active scavenging or active
scavenging with passive scavenging canisters. Isoflurane exposure was also lower for
researchers working with large animals compared to small animals. This difference is
due to the difference in anesthesia induction and maintenance techniques. Researchers
can induce anesthesia using injectable anesthetics and then intubate large animals, but
must use nose-cones for small animals. Both induction chamber and nose cones can
result in waste anesthetic gas due to leaks and opening of the induction chamber. The
species of animal used during procedures did not have an effect on isoflurane exposure.
Procedure time and number of animals did not have an effect of isoflurane exposure on
researcher working with mice. Researchers who were designated as the primary
individual conducting procedures had a higher exposure to isoflurane than researchers
who assisted in procedures.
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CHAPTER 5
COMPARISON OF PASSIVE AND ACTIVE SCAVENGING METHODS TO REDUCE
EXPOSURE TO ISOFLURANE IN RESEARCH LABORATORIES
ABSTRACT
The two most common scavenging methods for isoflurane gas are passive
scavenging canisters with activated charcoal and active scavenging. Passive
scavenging is the use of a material to adsorb the air pollutant. Passive scavenging
requires the pollutant to diffuse from the source into the scavenging material. In active
scavenging, the polluted air is pulled out of the room by building exhaust through a
vacuum line or ventilated hood. Refresh™, VaporGuard™, and F/Air™ are three brands
of passive scavenging canisters that were included in the study. Isoflurane concentration
was compared between four scavenging conditions (no scavenging, passive
scavenging, active scavenging, and combined active and passive scavenging). The
mean isoflurane concentration found without any controls was significantly higher
compared to active scavenging (10.23 ppm, %CV = 11.53 and 1.43 ppm, %CV = 15.38,
respectively). The mean isoflurane measured during the passive scavenging condition
was 10.35 ppm (%CV = 57.97). Overall, there was a significant difference in isoflurane
concentration between the conditions (p > 0.001). There was a slight difference in
isoflurane concentration between canister brands; ReFresh canisters had a lower mean
isoflurane concentration than the F/Air brand of canisters (6.48 ppm, %CV = 30 and
15.76 ppm, %CV = 50) (p = 0.04). However, mean isoflurane concentration while using
all three brands of canisters exceeded the NIOSH REL of 2 ppm for halogenated
anesthestic gases. Passive scavenging canisters are not equal to vacuum exhaust lines
in scavenging capabilities. Researchers should use active scavenging methods to
control isoflurane WAG exposures.
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INTRODUCTION
Gas leakage from face masks or nose cones, anesthetic machinery, and
malfunction of scavenging equipment are the primary sources of occupational exposure
to isoflurane waste anesthetic gas (WAG) (Hoerauf et al., 1996, Kelly et al., 2011, Todd
et al., 2013). As isoflurane is the primary anesthetic in the research setting, scientists
and laboratory personnel are at risk for occupational exposures to isoflurane. Available
literature has not provided an overall picture of health consequences associated with
occupational exposure to isoflurane. A few studies have demonstrated adverse health
effects, but the literature is not consistent. Low dose exposures typical of occupational
exposures have been found to cause damage to sister chromatids similar to damage
caused by cigarette smoking (Hoerauf et al., 1999). To reduce risk of health damage to
workers, best practice guidelines state that all WAGs should be kept to the smallest
amount possible (Barker et al., 1997).
Ways to control WAG include passive scavenging canisters, active vacuum
scavenging devices, ventilation through a heating, ventilating and air conditioning
(HVAC) system, as well as scavenging face masks and rebreathing circuits for larger
animals. The use of passive scavenging canisters may not result in the intended result of
lower isoflurane exposure. A study of three different brands of passive scavenging
canisters found that there was large variability in scavenging capability both between
brands and between canisters of the same brand (Smith et al., 2003). The study also
found that several canisters actually emitted isoflurane vapor after use. Studies of
isoflurane WAG in clinical settings found that passive scavenging canisters could
effectively control isoflurane concentration (Coleman et al., 1994, Imberti et al., 1995).
However, these studies overlook the effect of other WAG controls such as air exchanges
in the spaces and the use of intubation to maintain anesthesia, which could actually be
responsible for the low isoflurane concentration.
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Studies of active scavenging techniques have found that these techniques
efficiently control WAGs. Smith et al. (2002), found that fume hoods are able to
efficiently reduce WAG exposure to personnel. Another study found that an exhaust
vacuum line reduced isoflurane concentration during anesthesia induction and nosecone maintenance for small animals (Nesbitt et al., 2013). A study on dogs found that
active scavenging from the face-mask reduced isoflurane WAG (Friembichler et al.,
2011). Appropriate use of vacuum scavenging lines has also been shown to reduce
isoflurane concentration to close to the lower detection limit (Todd et al., 2013).
The literature on WAG exposure has reported several sources of isoflurane and
other WAG exposure. Kelly et al. (2011), reported in a study of ten different isoflurane
vaporizers that the vaporizers were highly inaccurate in delivering the isoflurane at the
concentration and flow rate set by the users. Inaccurate vaporizers may not only result in
an overexposure of isoflurane to users, it may also be dangerous for any patients or
animals, as they are not receiving the intended level of medication.
Leakage from anesthesia maintenance devices has been found to significantly
influence isoflurane exposure. Hoerauf et al. reported that use of laryngeal masks
resulted in higher exposure than intubation (Hoerauf et al., 1996). A study of rodents
found that isoflurane leakage from rodent nose-cones substantially contributed to
isoflurane exposure to workers (Smith et al., 2006). Modified nose-cones for rodents
were reported to help reduce this exposure. Nose-cones can be modified to be used with
an active scavenging line (Nesbitt et al., 2013) or with a simple diaphragm (Smith et al.,
2006, Todd et al., 2013).
Current guidelines published by professional veterinary societies to reduce WAG
concentration, state that the use of scavenging devices is the most effective way to
decrease waste anesthetic gases. The guideline goes on to say that both passive and
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active scavenging systems are effective if used properly (American College of Veterinary
Anesthesia and Analgesia, 2013). This statement seems to imply that passive and active
scavenging devices are equally effective, which early studies negate (Gardner, 1989,
Ward et al., 1982). We tested these recommendations by comparing isoflurane
concentration in a procedure room when using passive scavenging canisters, active
scavenging, and a combination of passive and active scavenging. We used these
comparisons to test the hypothesis that passive scavenging canisters will reduce
isoflurane WAG to two parts per million (ppm) or below during 30 minutes of exposure.
METHODS
Isoflurane concentration was measured during four environmental conditions in
the same room. The room was part of the Comparative Medicine facility, where many
animal procedures take place. Room dimensions were 10 feet 9 inches by 11 feet 5
inches with a ceiling height of 9 feet for a volume of 1026.54 feet3 (312.89 meters3).
Ventilation for the Comparative Medicine facility was 27.96 air exchanges per hour as
reported by the Comparative Medicine facility.
The four environmental conditions were “no scavenging” in which no effort was
made to reduce isoflurane vapor in the room, “passive scavenging” in which we used
activated charcoal canisters to control isoflurane vapor. The other two conditions
involved the use of an exhaust vacuum line. The “active scavenging” condition was
defined as the use of the vacuum line alone and the “combined scavenging” condition
was the use of the vacuum line in tandem with passive scavenging canisters.
Isoflurane was introduced into the environment and controlled using a model
vapor 19.1 isoflurane vaporizer (Drägerwerk, Lübeck, Germany) that had been serviced
and calibrated within the past year. All hoses and anesthesia equipment were checked
for leaks each day prior to use. Passive scavenging canisters were weighed daily for
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four days prior to and after exposure to isoflurane gas to determine weight variability.
The performance of the balance (Sartorius, Model L 2200 P, Gottingen, Germany), used
to weigh the canisters was evaluated daily with a set of eight standard weights ranging in
weight from 50 grams (g) to 500 g.
No Scavenging
Baseline isoflurane concentration was measured in the procedure room using a
MIRAN Sapphire model 205 BXL (Thermo Fisher Scientific, Franklin, MA) infrared
ambient air analyzer. An isoflurane vaporizer was connected to a rodent nose cone
using flexible hosing. Isoflurane was introduced into the procedure room for thirty
minutes at a concentration of 1.5% and flow rate of 1 liter per minute (L/min). Isoflurane
concentration in the room was measured and logged at 90-second intervals until
ambient isoflurane concentration returned to baseline. The 90-second interval was the
shortest possible interval allowed by the instrument. The procedure was conducted a
total of three times, consecutively, on one day.
Absorption of Isoflurane by Passive Scavenging Canisters
Three brands of passive scavenging canisters (F/Air™, VaporGuard™,
ReFresh™) were weighed once daily for four days. A passive scavenging canister was
connected to the exhaust line of a rodent nose cone with cotton plug representing a
mouse, attached to the isoflurane vaporizer. Isoflurane was released for 30 minutes at a
concentration of 1.5% and flow rate of 1 L/min. Isoflurane concentration in the room was
logged at 90-second intervals until isoflurane concentration returned to baseline.
Canisters were weighed immediately after exposure to isoflurane. Canisters were
weighed once daily for three days after isoflurane exposure. The procedure was
conducted with a total of five canisters per brand and each canister was tested once
(n=15). This experiment was carried out in one day in triplicate. (Figure 5.1).
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Figure 5.1: Control comparison setup. A) Isoflurane was measured using a MIRAN
Saphhire direct reading instrument. B) Isoflurane was introduced into the room via a
nose-cone with cotton plug representing a mouse. Isoflurane vaporizer line, passive
canister, and vacuum line can be seen in the picture.
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Effectiveness of Active Scavenging to Control Isoflurane Concentration
Flexible tubing was connected to the building exhaust and placed near the nose
cone. Isoflurane was released for thirty minutes at a concentration 1.5% and flow rate of
1 L/min. Isoflurane concentration was recorded and logged at 90-second intervals until
the isoflurane concentration returned to baseline. The active scavenging was
discontinued after isoflurane was turned off. The procedure was conducted three times.
The room was allowed to return to baseline isoflurane concentration between trials.
Effectiveness of a Combined Passive and Active Scavenging Technique
A passive scavenging canister was attached to the exhaust port of the nose
cone. An active vacuum line as described above was placed near the nose cone.
Isoflurane was released into the room for thirty minutes at a concentration of 1.5% and
flow rate of 1 L/min. Isoflurane concentrations were recorded and logged at 90-second
intervals until the room returned to baseline. Active scavenging was discontinued
immediately after isoflurane was turned off. The passive canister was weighed
immediately after isoflurane exposure. The procedure was conducted three times for
each brand of canister (n=9).
Statistical Analysis
All statistical analysis was performed using SAS 9.3 software (Cary, NC). Linear
regression and correlation statistics were used to determine whether daily
measurements of known weight varied significantly over time. Linear regression analysis
and correlation statistics were used to determine whether canister weight varied over
time.
Repeated measures analysis of variance (ANOVA) for one factor was used to
determine whether the isoflurane concentration was significantly different using
scavenging methods compared to the no scavenging condition. Post hoc Tukey’s
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adjustment was used to compare differences between groups. A p < 0.05 was
considered significant. Repeated measures (ANOVA) for one factor was used to
determine whether individual trials of the same condition varied significantly. A p < 0.05
was considered significant. Repeated measures (ANOVA) for one factor was used to
determine whether isoflurane concentration differed between each passive canister
brand. Post hoc Tukey’s adjustment was used to compare differences between groups.
Only measurements from the passive scavenging condition were used in the analysis. A
p < 0.05 was considered significant.
RESULTS
Canister Weight
The performance of the balance was evaluated with eight known weights over
eighteen days. There was no change in the balance accuracy over time for any of the
standard weights (p > 0.05). Linear regression analysis also showed no change in
weight over time for the standard weights (p > 0.05) (Table 5.1).
Table 5.1: Balance Calibration
Known
Weight
50
100
200
300
350
400
450
500

n
18
18
18
18
18
18
18
18

Mean (SD), g
50.17 (0.01)
99.95 (0.01)
200.14 (0.05)
300.10 (0.05)
350.28 (0.05)
400.32 (0.02)
450.49 (0.03)
500.25 (0.12)

Range, g
50.14—50.19
99.93—99.96
200.07—200.22
300.03—300.18
350.20—350.36
400.28—400.34
450.42—450.52
499.78—500.30

P - value
0.18
0.43
0.93
0.79
0.33
0.22
0.61
0.13

Canister weight for the ReFresh™ brand of canister was not correlated with time.
Canisters did gain weight after exposure to isoflurane. However, the weight gain was
small and the canisters did not lose weight after exposure. One of the VaporGuard™
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and two of the F/Air™ canisters were marginally correlated with time (p = 0.04). All
canisters gained a small amount of weight after exposure to isoflurane. Significant
correlation over time may be related to weight gained due to isoflurane exposure. The
weights of the other VaporGuard™ and F/Air™ canisters were not correlated with time
(Table 5.2). Overall the weight of all of the canisters was stable over time.
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Table 5.2: Canister Weight Before and After Isoflurane Exposure
Before
After
Canister
N
Mean (%CV), ppm Range, ppm
Mean (%CV), ppm Range, ppm
ReFresh 1
4
396.32 (0.01)
396.26—396.35
397.12 (0.07)
396.83—397.48
ReFresh 2
4
381.17 (0.01)
381.13—381.21
381.35 (0.09)
381.00—381.80
ReFresh 3
4
386.29 (0.01)
386.23—386.33
386.61 (0.08)
386.28—387.02
ReFresh 4
4
390.77 (0.01)
390.73—390.82
391.41 (0.07)
391.12—391.78
ReFresh 5
4
403.02 (0.01)
402.94—403.06
403.53 (0.06)
403.26—403.86
VaporGuard 1
4
369.11 (0.03)
368.93—369.23
370.14 (0.25)
369.14—371.31
VaporGuard 2*
4
364.35 (0.04)
364.13—364.48
363.50 (0.26)
362.45—364.74
VaporGuard 3
4
367.71 (0.05)
367.46—367.85
367.30 (0.27)
366.21—368.58
VaporGuard 4
4
370.22 (0.05)
369.99—370.35
369.89 (0.24)
368.88—371.00
VaporGuard 5
4
369.08 (0.04)
368.87—369.19
369.00 (0.25)
367.95—370.13
F/Air 1
4
293.67 (0.03)
293.58—293.80
295.22 (0.07)
294.99—295.50
F/Air 2
4
292.50 (0.03)
292.43—292.58
293.02 (0.06)
292.82—293.21
F/Air 3
4
311.18 (0.03)
311.10—311.27
311.21 (0.06)
311.00—311.45
F/Air 4
4
292.98 (0.04)
292.89—293.11
293.31 (0.09)
293.11—293.69
F/Air 5
4
294.38 (0.03)
294.30—294.47
295.41 (0.07)
295.18—295.68
*Indicates significance at 0.05 level

p-value
0.06
0.9
0.43
0.1
0.12
0.45
0.01*
0.08
0.09
0.26
0.02*
0.12
0.41
0.45
0.04*
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Canister Comparison
The mean isoflurane concentration while using passive scavenging canisters was
above 2 ppm for all brands of canisters. The highest isoflurane concentrations were
recorded while using the F/Air™ canisters alone (Table 5.3). Comparison between the
no scavenging condition and each of the passive scavenging canisters brands alone
showed a slight difference in isoflurane concentration (p = 0.03). Post hoc Tukey’s
analysis showed a significant difference between ReFresh and F/Air canisters. No other
comparisons were significant. Isoflurane concentration while using active scavenging
and passive scavenging canisters was not included in the canister comparison.
Table 5.3: Isoflurane Exposure while using Passive Scavenging Canisters
Canister
n
Mean (%CV), ppm
Range, ppm
No Scavenging
3
10.23 (11.53)
9.11—11.47
*ReFresh
5
6.48 (29.94)
4.22—8.79
VaporGuard
5
8.80 (17.50)
6.92—10.56
*F/Air
5
15.76 (49.87)
5.58—23.88
*Indicates significance at the 0.05 level

Comparison of Scavenging Techniques
Repeated measures ANOVA model showed that type of scavenging was a
significant factor in isoflurane concentration (p < 0.0001). Post hoc analysis of
comparisons showed isoflurane concentration differed between no scavenging and
combined scavenging, passive scavenging and active scavenging, and passive
scavenging and combined scavenging at the 0.05 significance level. Comparisons of no
scavenging and active scavenging alone showed that isoflurane concentration was also
different between active scavenging and no scavenging (p < 0.0001) (Figure 5.2).
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Isoflurane Exposure during No Scavenging and
Active Scavenging Conditions
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Figure 5.2: Isoflurane exposure without scavenging and while using an exhaust
vacuum line. Isoflurane exposure was significantly lower while using active
scavenging.
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The mean isoflurane concentrations for the no scavenging and passive
scavenging conditions were very similar (10.23 and 10.35, respectively) and higher than
for the active and combined scavenging conditions (1.43 and 0.59, respectively) (Table
5.4). Both the “no scavenging” and passive scavenging conditions resulted in a mean
isoflurane concentration well above the NIOSH REL of two ppm. Isoflurane
concentration measured over time was similar between the “no scavenging” condition
and while using ReFresh and VaporGuard canisters. Isoflurane concentration was
higher while using F/Air canisters compared to the other passive canisters (Figure 5.3).
Table 5.4: Isoflurane Exposure during Experimental Scavenging Conditions
Condition
n
Mean (%CV), ppm
Range, ppm
No Scavenging
3
10.23 (11.53)
9.11—1.47
Passive Scavenging
15
10.35 (57.97)
4.22—23.88
Vacuum Line
3
1.43 (15.38)
1.28—1.68
Combined Scavenging
9
0.59 (45.76)
0.07—0.28
P-value < 0.0001

Active scavenging and combination scavenging resulted in a mean isoflurane
concentration below two ppm. The maximum isoflurane concentration was also below
two ppm while using these scavenging techniques.
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Isoflurane Concentration While Using Passive Scavenging
Canisters
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Figure 5.3: Isoflurane exposure during without scavenging and while using
passive scavenging canisters. Isoflurane exposure was similar without
scavenging and while using canisters.
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Comparison of Active and Combined Scavenging Techniques
Combination scavenging technique combined a passive scavenging canister with
an active vacuum scavenging line. Isoflurane concentration was reduced approximately
50% compared to active scavenging alone. Repeated measures ANOVA with post hoc
Tukey’s comparison analysis showed that the difference in isoflurane concentration was
not significant. Repeated measures ANOVA also showed that there was no difference in
isoflurane concentration between canister brands when used in combination with active
scavenging (Figure 5.4).
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Isoflurane Concentration With Combined Scavenging
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Figure 5.4: Isoflurane exposure was not statistically different between the
vacuum line and the vacuum line combined with a passive scavenging canister.
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DISCUSSION
Mean isoflurane exposure was below the NIOSH REL of two ppm for
halogenated anesthetic gases when using an active scavenging source. The NIOSH
REL is a 1-hour limit, meaning that exposure to halogenated gases should not be above
two ppm, when used for 1-hour or greater. Although this standard was developed before
the introduction of isoflurane as a halogenated anesthetic gas, it is the only guidance
currently available that has been developed in the U.S. The American Conference of
Governmental Industrial Hygienists (ACGIH) has listed isoflurane among chemical
substances that are under study for the year 2015. This is the only U.S. body likely to
publish an updated standard for isoflurane in the near future. A workplace exposure limit
(WEL) of 50 ppm over an 8-hour work day has been adopted by member states of the
European Union (United Kingdom Health and Safety Executive, 2013). However, we
have shown that the NIOSH two ppm standard is achievable if active scavenging
methods are employed. Examples of active scavenging methods are the use of a
vacuum exhaust line similar to what was used in this study and exhausted chemical
safety hoods such as class II BSCs.
Passive scavenging canisters, when used alone, did not reduce isoflurane
concentration to an acceptable level. The passive scavenging canisters as a whole were
not different from the no scavenging condition. Little manufacturer information is
available concerning the charcoal used in the canisters and the construction of the
canisters themselves, as this is proprietary information. It is difficult to determine what
differences between canisters brands may be related to scavenging capability. All of the
passive scavenging canisters contained activated charcoal, which is supposed to control
isoflurane WAG by adsorbing the isoflurane to the charcoal. The problem with this
strategy is that there is no air flow being directed into the canisters. We also observed
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that isoflurane concentration was actually higher when using the F/Air canisters than
when not using any scavenging. It is possible that any isoflurane-contaminated air that
entered the canister actually exited the canister before the charcoal could adsorb any
isoflurane. This is an effect known as channeling (Smith et al., 2003).
Flow rate may impact how well a passive canister adsorbs isoflurane because of
this channeling effect. Higher flow rates are more likely to overload the canisters, thus
reducing their ability to retain air long enough for the isoflurane to be exposed to the
activated charcoal long enough to adsorb to it. We used a lower flow rate of 1.5%, to
recreate what was used by a majority of the researchers to maintain anesthesia in
rodents. We used a concentration of 1% isoflurane as this was the concentration most
often used to maintain anesthesia.
Surgical wrap was used to mimic the effect that an animal would have in blocking
some air flow from the nose-cone. The middle of the surgical wrap was shaped to be
similar to the nose of a mouse and secured in the nose-cone using surgical tape. We did
not use live animals because this could have resulted in random error due to the
variability in the shapes of the animals’ noses and respiration. The main objective of the
study was to determine the effectiveness of WAG controls. As such, we kept to a
minimum variables that could influence isoflurane exposure. This is also why only one
procedure room was used during the course of the study. The procedure room was
located in a secure, environmentally controlled underground facility. This allowed for the
equipment to be housed in the room to reduce any variability that could be caused by
exposure to the outside air or transport. The environmental controls ensured that
temperature and relative humidity were stable throughout the study. Air exchanges were
controlled by the facility.
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Passive scavenging canisters are not a cost effective way to control isoflurane
WAG. The purchasing cost of the canisters is between $8 and $10 each. The cost
increases when disposal of the used canisters is considered. Disposal of the canisters is
regulated by the Environmental Protection Agency (EPA) and the Department of
Transportation (DOT). Canisters must be handled as EPA regulated D001 ignitable
waste and shipped outside of facilities for disposal following DOT NA1361 regulations
(Department of Transportation, 2010). The cost for canister disposal at our institution is
$180 for approximately 60 canisters. If one canister is used per day the total cost of
passive scavenging is approximately $4,750 per year. The active scavenging vacuum
line greatly reduced isoflurane concentration. Costs associated with vacuum line
scavenging will be based on individual exhaust systems and are difficult to quantify.
However, active scavenging with a fume hood is likely to be as or more efficient than a
vacuum line. Costs associated with a fume hood are initial purchase and installation and
energy consumption. Conventional bypass fume hoods use approximately 35,000
kilowatt-hours (kWh) of electricity per unit and costs approximately $6,000 in energy use
each year (U.S. Department of Energy, 2015). This cost is based on 24-hour per day
use with a fully open sash (29 inches). Energy costs dramatically decline as the sash
opening is reduced; energy associated with a sash opening of 5 inches is approximately
5.500 kWh and $1000 (U.S. Department of Energy, 2015). Energy costs will differ by city
and state; however energy use will remain approximately the same.
It is possible that researchers may have a false sense of security when using
passive scavenging canisters to control WAG. As we have shown, passive canisters do
little to reduce isoflurane exposure to researchers. However, several researchers at the
institution relied solely upon passive canisters to control WAG. Researchers may
overestimate the protection offered by passive canisters. Researchers, who have access
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to BSCs, fume hoods, or vacuum exhaust lines should be encouraged to utilize these
tools responsibly by keeping the sash as low and possible, especially when not in use. If
used responsibly, the energy costs associated with a fume hood will be considerably
less than the cost associated with passive scavenging.
We have observed several researchers at our institution using active scavenging
in combination with passive scavenging canisters. The results of this study show that
there is no real benefit to using passive scavenging canisters with an active scavenging
vacuum line. For the purpose of this study, it was assumed that ventilated hoods would
reduce isoflurane exposure either as much as or greater than an active scavenging
vacuum line. Therefore, the ability of ventilated hoods to reduce isoflurane exposure has
been inferred based on the active scavenging vacuum lines.
A strength of this study is that we measured isoflurane concentration using a
direct reading instrument. The instrument was set to measure isoflurane in an operator’s
breathing space. This allowed us to determine the effectiveness of different controls in
protecting an employee from isoflurane vapors. Smith and Bolon (2003) compared the
scavenging capabilities of passive scavenging canisters by measuring isoflurane
concentration at the canister. This approach is sufficient in determining how well the
passive canisters retain isoflurane vapor, but is not sufficient to determine if they are
protective of the operator.
Several portable active vacuum scavenging instruments are now available to
control WAGs. These devices use a pump to draw air into a reservoir of activated
charcoal. These devices could be useful in rooms that do not have a source of active
scavenging available. The use of these devices has not been reviewed in the scientific
literature. A logical next step for this study would be to evaluate several of these devices
to determine how effectively they control isoflurane WAG.
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CONCLUSION
Isoflurane concentration was lower when using an active scavenging source
compared to using no scavenging or passive scavenging canisters. Isoflurane
concentration was only slightly lower when using passive scavenging canisters.
However, using passive scavenging canisters resulted in a mean isoflurane
concentration above the NIOSH REL of two ppm. The use of active scavenging and
passive scavenging canisters, reduced isoflurane concentration by approximately 50%
compared to active scavenging alone. However, there was no statistical difference in
active scavenging and combined scavenging when compared to all experimental
conditions.
The most cost effective control method to reduce isoflurane exposures in
laboratory researchers is active scavenging. Active scavenging includes fume hoods
(including biosafety cabinets) and vacuum lines. Active scavenging techniques reduced
isoflurane exposures to laboratory researchers below the NIOSH REL for anesthetic
gases of 2 ppm. Passive canisters are not effective in reducing exposures below the
NIOSH REL. Combining the active and passive scavenging techniques further reduced
exposures, though this reduction was not statistically significant from the active
scavenging data alone. Given the cost of purchasing new canisters and discarding used
ones, this approach may not be cost effective.
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CHAPTER 6
CONCLUSION
This dissertation identified possible overexposures to medical researchers who
use isoflurane. However, because an isoflurane-specific standard is not currently
available, we are not able to conclude if these researchers are at a risk of developing
health hazards associated with isoflurane. Nevertheless, the data underscores the need
for an occupational exposure limit that includes isoflurane. The NIOSH REL for
halogenated anesthetic gases is the closest standard applicable to isoflurane. The
NIOSH REL needs to be revised to include isoflurane. At the time the standard was
developed isoflurane and other newer generation halogenated anesthetic gases were
not available.
In addition, this standard was written to protect health care professionals. The
use of isoflurane has shifted to the veterinary and research fields. These populations
need to be considered when revising the standard. When the NIOSH standard was
developed there was insufficient health data available to determine what exposure
concentrations of halogenated gases could be determined as reasonable safe. The
result was a standard which was based mostly upon the sampling and detection
techniques at the time. Isoflurane has been in use for decades.
Unfortunately, while research and technology have moved forward in sampling
and analysis, epidemiological research on human health effects has remained stagnant.
The systematic review of the literature in chapter two revealed that most studies with
health effects data were focused on the healthcare population and a mixed anesthetic
gas exposure. Future studies need to be conducted with study populations in the
veterinary or research fields. These are the fields in which isoflurane is used the most
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often. Studies looking for long-term health outcomes also need to be conducted. There
is evidence that isoflurane may cause genetic mutations.
Employees in the research field are at risk for over exposure to isoflurane. In the
study of dental researchers in chapter three, the most important source of isoflurane was
the nose-cone. This was an unanticipated result, as we assumed that the induction
chamber would be the greatest source. It is important to consider all possible sources of
isoflurane WAG to accurately assess exposure and when designing controls. A
ventilation control that could be manipulated for use with the induction chamber and the
nose cone greatly reduced isoflurane exposure to the researchers. The isoflurane
exposure was reduced a maximum of 97% and a mean of 86% after the installation and
use of this control.
A study of several researchers and procedures in chapter four revealed
scavenging technique and researcher roles during a procedure greatly affect isoflurane
exposure. Researchers who used an active scavenging technique such as a BSC or
exhaust vacuum line had significantly lower isoflurane exposures than researchers who
relied solely on passive scavenging canisters. This indicates that passive scavenging in
conjunction with normal room ventilation is not sufficient to protect researchers from over
exposure. Almost one third of the researchers monitored for the study had an isoflurane
exposure above the NIOSH REL of two ppm for halogenated anesthetic gases.
Species of animals on which the procedures were being performed was not
associated with isoflurane exposure. This was a surprise because we would expect
larger amounts of isoflurane to be used on larger animals, thus increasing the possibility
of overexposure. However, large animals such as pigs are intubated to maintain
anesthesia. This should have reduced the most likely source of the isoflurane, which is
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the nose-cone or face-mask. This result may have been impacted by the small sample
size available for large animal procedures.
In the control comparison study in chapter five, passive scavenging canisters did
not reduce isoflurane exposure. Passive scavenging canisters also had a high variance
between brands and between canisters of the same brand. Canister weight was stable
before isoflurane exposure, which indicated that environmental conditions should not
have had an impact on canister performance. Canister weight after exposure was also
fairly stable which indicated that canisters were not likely to off-gas isoflurane. The lack
of off-gassing, combined, with the high isoflurane concentrations measures in the room
indicated that the canisters were not able to adsorb isoflurane efficiently. Active
scavenging using an exhaust vacuum line greatly reduced isoflurane concentration.
There was no significant difference in isoflurane concentration between the vacuum lines
alone compared to using passive canisters with the vacuum line. It is recommended that
researchers use of active scavenging methods to control isoflurane WAG.
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Isoflurane in combination with other anesthetic gases, is likely to be associated
with adverse human health effects such as genetic damage and changes in cellular
functions. These changes could be related to other negative health outcomes such as
CNS toxicity, reproductive toxicity, and organ toxicity. Researchers using isoflurane to
anesthetize animals are at risk for high exposures to isoflurane. Researchers should use
active scavenging methods to control isoflurane WAG. Active scavenging may not be
reasonable in all research situations due to cost or limited space. Portable active
scavenging systems are now available, which may be beneficial in these instances.
These systems combine the portability of passive scavenging canisters with pump to pull
polluted air into the activated charcoal. The portable active scavenging systems have yet
to be evaluated in the literature. These devices should be investigated to determine if
they are an efficient control for isoflurane
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APPENDIX A: FULL PUBMED SEARCH STRATEGY FOR SYSTEMATIC REVIEW

((((((((occupation[tiab] OR occupational[tiab]))) AND ((expose[tiab] OR
exposed[tiab] OR exposure[tiab])))) OR "occupational exposure") OR ((("Occupational
Exposure"[Mesh]) OR "Occupational Diseases"[Mesh]) OR "Environmental
Exposure"[Mesh:NoExp]))) AND ((((("Isoflurane"[Mesh]) OR isoflurane[tiab])) OR
("anaesthetic gas" OR "anaesthetic gases")) OR ("anesthetic gas" OR "anesthetic
gases")) Filters: Humans.
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APPENDIX B: FULL Embase SEARCH STRATEGY FOR SYSTEMATIC REVIEW

Search Queries
No.

Query

Results

Date

#15 ((('occupational exposure'/exp OR 'occupational
disease'/exp) AND ('isoflurane'/exp OR (isoflurane:ti OR
isoflurane:ab) OR ('anesthetic gas':ti OR 'anaesthetic
gas':ti) OR ('anesthetic gases':ti OR 'anaesthetic
gases':ti) OR ('anesthetic gases':ab OR 'anaesthetic

70 19 Dec 2014

gases':ab) OR ('anesthetic gas':ab OR 'anaesthetic
gas':ab) OR ('anesthetic gas':ab OR 'anaesthetic
gas':ab))) AND 'human'/de) AND ([embase]/lim NOT
[medline]/lim)
#14 [embase]/lim NOT [medline]/lim

6564799 19 Dec 2014

#13 (('occupational exposure'/exp OR 'occupational
disease'/exp) AND ('isoflurane'/exp OR (isoflurane:ti OR
isoflurane:ab) OR ('anesthetic gas':ti OR 'anaesthetic
gas':ti) OR ('anesthetic gases':ti OR 'anaesthetic
gases':ti) OR ('anesthetic gases':ab OR 'anaesthetic

378 19 Dec 2014

gases':ab) OR ('anesthetic gas':ab OR 'anaesthetic
gas':ab) OR ('anesthetic gas':ab OR 'anaesthetic
gas':ab))) AND 'human'/de
#12 ('occupational exposure'/exp OR 'occupational
disease'/exp) AND ('isoflurane'/exp OR (isoflurane:ti OR
isoflurane:ab) OR ('anesthetic gas':ti OR 'anaesthetic
gas':ti) OR ('anesthetic gases':ti OR 'anaesthetic
gases':ti) OR ('anesthetic gases':ab OR 'anaesthetic

483 19 Dec 2014

gases':ab) OR ('anesthetic gas':ab OR 'anaesthetic
gas':ab) OR ('anesthetic gas':ab OR 'anaesthetic
gas':ab))
#11 'isoflurane'/exp OR (isoflurane:ti OR isoflurane:ab) OR
('anesthetic gas':ti OR 'anaesthetic gas':ti) OR

23477 19 Dec 2014
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('anesthetic gases':ti OR 'anaesthetic gases':ti) OR
('anesthetic gases':ab OR 'anaesthetic gases':ab) OR
('anesthetic gas':ab OR 'anaesthetic gas':ab) OR
('anesthetic gas':ab OR 'anaesthetic gas':ab)
#10 'occupational exposure'/exp OR 'occupational
disease'/exp

183140 19 Dec 2014

#9

'anesthetic gas':ab OR 'anaesthetic gas':ab

458 19 Dec 2014

#8

'anesthetic gas':ab OR 'anaesthetic gas':ab

458 19 Dec 2014

#7

'anesthetic gases':ab OR 'anaesthetic gases':ab

667 19 Dec 2014

#6

'anesthetic gases':ti OR 'anaesthetic gases':ti

409 19 Dec 2014

#5

'anesthetic gas':ti OR 'anaesthetic gas':ti

164 19 Dec 2014

#4

'occupational disease'/exp

#3

'occupational exposure'/exp

65409 19 Dec 2014

#2

isoflurane:ti OR isoflurane:ab

13200 19 Dec 2014

#1

'isoflurane'/exp

20403 19 Dec 2014

132114 19 Dec 2014
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APPENDIX C: ASSESSMENT OF ISOFLURANE EXPOSURE TO RESEARCHERS
DURING ANIMAL PROCEDURES (CHAPTER 4)
Isoflurane
Exposure
Procedure Description
ID
(ppm)
Role
Scavenging Species
Acute Cardiac Disease
Model
Cardiac Arrest Treatment 1
Cardiac Arrest Treatment 1
Cardiac Arrest Treatment 2
Cardiac Arrest Treatment 2
Cardiac Arrest Treatment 3
Cardiac Arrest Treatment 3
Cardiac Arrest Treatment 4
Cardiac Arrest Treatment 4
Cardiac Arrest Treatment 4
Surgical Robot Test
Surgical Robot Test
Surgical Robot Test
Surgical Robot Test
Surgical Robot Test
Body Composition
Body Composition
Cardiac Arrest Treatment
Cardiac Arrest Treatment
Cardiac Arrest Treatment
Cardiac Arrest Treatment
Dissection (1)
Dissection (2)
Dissection (3)
Dissection (3)
Dissection (3)
Dissection (3)
Drug Pump Implantation
Embryonic Transfer
Surgery
Embryonic Transfer
Surgery
Heart Ultrasound
Heart Ultrasound
Humanized Liver Model
Humanized Liver Model
Intraperitoneal Injections
Intraperitoneal Injections

5679
2402
7894
2402
7894
2402
4608
2402
4608
4979
5162
3443
6295
5729
6017
1517
1235
7304
4608
2402
4399
5015
7776
1809
9131
4904
2102
7584

0.09
1.90
0.69
1.70
0.24
2.50
0.22
1.30
0.16
0.72
2.50
3.60
0.63
0.42
0.68
0.56
0.53
1.30
0.77
0.63
0.53
0.28
0.64
1.6
1.5
2.5
6.6
3.6

Secondary
Secondary
Secondary
Secondary
Secondary
Secondary
Secondary
Secondary
Secondary
Primary
Primary
Secondary
Primary
Secondary
Secondary
Primary
Primary
Primary
Primary
Secondary
Secondary
Primary
Primary
Secondary
Secondary
Primary
Primary
Primary

Passive
Passive
Passive
Passive
Passive
Passive
Passive
Passive
Passive
Passive
Active
Active
Active
Active
Active
Active
Active
Active
Active
Active
Active
Active
Active
Passive
Passive
Passive
Passive
Passive

Large
Large
Large
Large
Large
Large
Large
Large
Large
Large
Large
Large
Large
Large
Large
Small
Small
Small
Small
Small
Small
Small
Small
Small
Small
Small
Small
Small

2437

1.6

Primary

Passive

Small

8747
2074
3916
6279
4014
4257
1784

0.26
2.9
0.41
0.25
0.42
9.5
3.7

Secondary
Primary
Secondary
Primary
Secondary
Primary
Secondary

Passive
Passive
Passive
Active
Active
Passive
Passive

Small
Small
Small
Small
Small
Small
Small

84

Kidney Ultrasound
Liver Cancer Model
Liver Cancer Model
Liver Cancer Model
MRI
MRI
Skin Disease Model
Telemeter Implantation
Time Course Model
Time Course Model

2495
2636
2512
4637
4805
6138
9683
5201
4020
1925

1.5
2.10
2.50
1.80
0.61
0.15
0.12
2.20
0.25
0.25

Primary
Secondary
Primary
Secondary
Primary
Secondary
Primary
Primary
Primary
Secondary

Passive
Passive
Passive
Passive
Active
Active
Active
Passive
Active
Active

Small
Small
Small
Small
Small
Small
Small
Small
Small
Small
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APPENDIX D: ASSESSMENT OF ISOFLURANE EXPOSURE TO RESEARCHERS
DURING ANIMAL PROCEDURES (CHAPTER 4)
Cardiac Arrest Treatment in Pig
The research protocol involved one research animal per procedure. A total of 5 to
6 research personnel, two cardiovascular surgeons and four technicians, participated in
each procedure. The technicians induced anesthesia in the pigs using injection or cone
mask with 5% isoflurane at a flow rate of 1 liter per minute (L/min) for 4 to 5 minutes.
Pigs were intubated to maintain anesthesia with isoflurane at 1.5 to 2 % isoflurane at a
flow rate of 1 L/min until the completion of the research protocol. Pigs were kept under
anesthesia for 6 to 8 hours per procedure. A total of 5 procedures were observed for this
study. In four of the studies the animals were recovered, in the final procedure the
animal was euthanized with potassium chloride (KCl) and 5% isoflurane for 5 minutes.
The purpose of the research procedures were to injure and occlude either the left
or right carotid artery or the left or right descending aortic vessel to create a heart attack
in the animal. The research team would treat the animal with standard heart attack
treatments and the research treatment. The research treatment was micro-bubbles
activated with ultrasound. One technician was in charge of prepping animals for surgery
by placing IVs and intubating the animal. After the initial prep time the technician would
be in and out of the procedure room. Two other technicians assisted in the preparation.
During the procedure one technician recorded notes and another manipulated the
camera arm of the fluoroscope. A third technician assisted the main cardiovascular
surgeon to occlude the artery or blood vessel and then treat the occlusion. A second
cardiovascular surgeon operated the ultrasound during the treatment period.
After treatment the animals were either recovered or moved to an MRI for
imaging. Animals that underwent MRI imaging were placed on a cart with a portable
isoflurane vaporizer to maintain anesthesia during transport to the MRI facility. At the
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facility, the animals were transferred to the MRI chamber and isoflurane vaporizer.
During the MRI, scanning research personnel were in a separate room from the MRI,
away from isoflurane sources. After the MRI the animals were transported back to the
procedure room with the same equipment and recovered or euthanized. During recovery
vitals were monitored. After recovery, animals were transported back to their housing
area. The concentration for the field blanks were below the limit of detection of 0.04
ppm.
Surgical Robot Test in Pig
One Yorkshire pig was used during the testing of a surgical robotics instrument.
Anesthesia was induced using 5% isoflurane at flow rate of 1.5 L/min delivered by cone
mask. After induction the pig was intubated to maintain anesthesia. An active vacuum
line was run from the building exhaust to the animal during induction and intubation. The
pig was then transferred to the procedure room and placed on isoflurane at 2% at flow
rate of 1.5 L/min. Two technicians were involved in the preparation and intubation of the
pig. Each of the technicians was monitored for isoflurane exposure during the entire time
that they were present for the procedure.
A total of 15 individuals observed or participated in the robotics test. The
procedure began approximately 1.5 hours after the pig had been prepped for the
surgery. The abdominal cavity of the pig was opened and a minor gastrointestinal
surgery was performed. The researchers then attempted to perform the same procedure
using the robot. The purpose of the study was to further the use of non-invasive surgery
techniques using surgical robots. The procedure took approximately 45 minutes to
perform. Two researchers were monitored for isoflurane exposure during the procedure.
One researcher operated the surgical robot, the other researcher observed the
procedure.
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Two technicians then began cleaning up the procedure room and euthanizing the
pig. The pig was euthanized using KCl and 5% isoflurane. Isoflurane was turned off after
approximately 5 minutes. Vacuum scavenging was used during the surgical procedure
and turned off with the isoflurane. The technicians finished cleaning the room and
disposing of the pig within 1 hour. Both of the technicians were monitored during the
cleanup. The concentration for the field blank was below the limit of detection of 0.04
ppm.
Acute Cardiac Disease Model in Rabbit
Anesthesia was induced in the rabbit by injection. The rabbit was intubated with a
fully inflated cuff and anesthesia was maintained at 1.5—2% isoflurane at flow rate of 1
L/min. An F/Air™ canister was used to scavenge waste anesthetic gas. A non-sterile
technician assisted in taking notes and moving non-sterile instruments. The technician
was monitored during the procedure. A surgeon opened the abdominal cavity of the
rabbit and placed a blood flow monitor on the renal vein. The surgeon was not monitored
due to concerns of maintaining a sterile surgical area. Active vacuum lines were
available in the procedure room, but were not used. The procedure took approximately 1
hour to complete. The rabbit was recovered by the technician for 3 hours and then taken
back to its housing area. The technician was monitored for the entire procedure and
recovery time. The isoflurane concentration for the field blank was below the limit of
detection of 0.04 ppm.
Cardiac Arrest Treatment in Rat
Anesthesia was induced using a 1 gallon ice cream container as induction
chamber. The anesthesia induction was not monitored. After induction the rat was
placed on a nose cone and shaved for procedure. Anesthesia was maintained at 1.5—
1.75% isoflurane at a flow rate of 1 L/min for approximately 1.5 hours. During the
procedure, a technician tied off left ascending cardiac vessel and prepared rat for
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cardiovascular injury. The technician used an active vacuum line and F/Air™ canister to
scavenge isoflurane vapors. The technician was monitored for the entire duration of
exposure.
A second technician performed the injury to the vessel to induce a heart attack.
The technician then treated the rat using ultrasound activated micro-bubbles. A
cardiovascular surgeon operated the ultrasound during the treatment. A third technician
assisted with the ultrasound and surgery. All participants were monitored for isoflurane
during the procedure. The animal was recovered after 1.5 hours and returned to its
housing. The concentration for the field blank was below the limit of detection of 0.04
ppm.
Telemeter Placement in Rats
A researcher induced anesthesia in rats using induction chamber with isoflurane
at 3% at flow rate 1 L/min for 5—15 minutes. Animals were moved to surgical area on
bench and placed on nose-cone to maintain anesthesia. Anesthesia was maintained at
2% isoflurane at a flow rate of 1 L/min.
Animals were secured to the surgical area, shaved, and swabbed with
iodine solution. A sterile cover was placed over the animal with a cut-out to expose
surgical area. Researcher opened the animal’s abdomen and chest, making two
separate cuts. Telemeter device was placed in abdomen with leads in the chest. The
researcher sutured abdomen and chest openings. Procedure time was approximately 1
hour per animal. The researcher placed one telemeter device in a total of three rats
during the monitoring period. A class 2 BSC and active vacuum ports were available, but
not used. The researcher used ReFresh canisters to scavenge WAG from the induction
chamber and nose-cone. The isoflurane concentration for the field blank was below the
limit of detection of 0.04 ppm.
Intraperitoneal Injections in Rat
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Twelve rats were injected once daily for seven days. Two researchers were
monitored for isoflurane exposure during one of the injection periods. One researcher
weighed the rats. The second researcher prepared the injections based on the rat’s
weight. The first researcher placed the animals in the induction chamber and performed
the injections. The researcher did intraperitoneal injections into the peritoneal cavity of
the rat.
Anesthesia was induced using 4% isoflurane at a flow rate of 2 L/min for 5
minutes; the flow rate was then reduced to a flow rate of 1.5 L/min. The induction
chamber was placed on a bench top and attached to an F/Air™ canister. A class 2 BSC
and active vacuum ports were available, but not used. The injections took approximately
15 minutes to perform. The researchers returned the animals to the housing area and
cleaned up. The concentration for the field blank was below the limit of detection of 0.04
ppm.
Liver Cancer Model in Rat
A total of four rats and three researchers participated in the protocol. Anesthesia
was induced in the rats using an induction chamber placed inside a class II BSC. An
F/Air™ canister was attached to the induction chamber. Anesthesia was induced at 4—
5% isoflurane at a flow rate of 2 L/min for approximately 5 minutes. Rats were then
removed from the induction chamber and placed on the procedure table. Isoflurane was
delivered at 1% at a flow rate of 1 L/min using a nose cone on the procedure table. The
nose-cone was fitted with a rubber septum and the rat’s entire head was placed in the
nose cone. An F/Air™ canister was used for scavenging isoflurane from the nose cone.
The rat was shaved and secured to the surgical procedure area.
The abdominal cavity was opened and intestines were gently placed to the side
of the animal. The researchers clamped the bile duct and then injected cancer cells into
the liver. The purpose of this procedure is to induce liver tumors in the rats. The
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researchers then suture the inner abdominal wall followed by the outer skin of the
abdomen. The researchers held the rats for approximately 3—5 minutes to warm the
animals. The rats were placed in the BSC on a heating pad to recover. The procedure
was performed on three rats in succession. The researchers then took a 30 minute
break and performed the procedure on a fourth animal.
The researchers took turns inducing anesthesia, prepping the animal, performing
the procedure, suturing the surgery site, and recovering the animals. One researcher
was in and out of the room preparing the cancer cells for injection. This researcher
performed the fourth procedure. The other two researchers were in the room for the
duration of the research. An active vacuum line for the procedure table was available,
but not used. The concentration for the field blank was below the limit of detection of
0.04 ppm.
Body Composition of Mice
Body composition procedures were monitored for isoflurane two separate times
with two different technicians. A technician performed body composition measurements
on 23 mice using a dual X-ray absorptiometry (DEXA) machine. The technician induced
anesthesia in the mice using 2.5—3% isoflurane at a flow rate of 1 L/min in a slide top
induction chamber. The induction chamber was placed on a table outside of a nearby
class 2 BSC. After anesthesia was induced, the technician transferred the animal to the
DEXA machine in the BSC. Anesthesia was maintained using the nose cone of the
DEXA machine at 2% isoflurane at a flow rate of 1 L/min. Mice remained on the DEXA
machine for approximately 4 minutes for the scan to complete. Mice were then removed
and recovered in cages. The technician placed a lead screen in front of the BSC during
the scan. Two VaporGuard™ canisters were used to scavenge waste gas. One canister
was attached to the induction chamber and one was attached to the DEXA machine and
placed in the hood. Both canisters were laid on their sides. The procedure and cleanup
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lasted for approximately 1.5 hours total. The technician refilled the isoflurane vaporizer
outside of the hood after the procedure. The technician placed the mice in the housing
facility after the procedure. The technician was monitored for isoflurane exposure during
the entire procedure.
A second body composition procedure was conducted with 15 mice and a
separate technician. The technicians each used the same protocols for the body
composition measurements. The total procedure time for this procedure was
approximately 1 hour and 15 minutes. The technician used 1.5% isoflurane at a flow rate
of 1 L/min to induce and maintain anesthesia in the mice. One F/Air™ canister was
attached to the induction chamber outside of the BSC and one VaporGuard™ canister
was attached to the DEXA machine inside the BSC.
The isoflurane concentration for the field blank was below the limit of detection of
0.04 ppm for this first procedure and less than 0.26 ppm for the second.
Embryo Transfer in Mice
Researchers prepared embryos for transfer. Five female mice were implanted
with the embryos. One researcher used the isoflurane in the open-drop method to
anesthetize the mice individually. The second researcher performed the transfer surgery
in a laminar flow hood. A Pure-Guard™ with an Enviro-Pure™ passive scavenging
canister was used to scavenge waste isoflurane gas. Each surgery lasted approximately
five minutes. The isoflurane concentration for the field blank was below the limit of
detection of 0.04 ppm.
Dissection 1: Mice Pups
Three mice pups were euthanized in a class II BSC with isoflurane using the
open-drop method. The mice pups were placed in a plastic canister with 0.1 milliliters
(mL) of isoflurane placed on a paper towel. The pups were removed one at a time and
dissected. Organs were collected for further analysis. The canister was open for
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approximately 30 seconds at a time. The procedure took approximately 15 minutes and
was completed in the BSC. The researcher performing the procedure was monitored for
isoflurane exposure during the procedure and the cleanup. The isoflurane treated paper
towels were left in the canister in the hood. After approximately two hours the paper
towels were disposed of in the biohazard waste.
The isoflurane concentration for field blank was below the detection limit of 0.04
ppm.
Dissection 2: Mice
A technician euthanized and dissected a total of ten adult mice. The mice were
euthanized using isoflurane and the open-drop method. Five mice were placed in a
desiccator jar in a class 2 BSC with paper towels treated with approximately 25 mL of
isoflurane. After the mice are euthanized they were removed from the jar as a group and
transferred to the bench for dissection. The leg tissue and knee joints were collected
from each mouse. Two groups of five mice were euthanized and dissected. The
technician was monitored for isoflurane exposure during the entire procedure. The
procedure and cleanup time was approximately 45 minutes. The paper towel was
removed from the desiccator jar and left in the hood for approximately 1 hour then
disposed of in the biohazard waste.
The isoflurane concentration for the field blank was below the detection limit of
0.04 ppm.
Dissection 3: Mice
Four researchers euthanized and dissected a total of four mice. The mice were
anesthetized individually using 2.5% isoflurane at a flow rate of 1 L/min in a clip top
induction chamber. The induction chamber clip was not secured between animals. A
technician and three students sat in a circle around a table to conduct the procedure.
The technician sat closest to the induction chamber and placed and removed the mice
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from the chamber. A student sat across from the technician. This student weighed the
animals and the organs collected from the dissected animals. A second student sat next
to the technician and assisted by dissecting the mice with the technician. The final
student kept notes for the procedure and placed the collected organs in collection vials.
The group worked together in an assembly line like manner. The procedure and cleanup
was completed in approximately 40—45 minutes. Isoflurane was actively used for
approximately 20 minutes.
A ReFresh passive canister was attached to the induction chamber to scavenge
WAGs. There was no access to active vacuum lines or a ventilated hood in the room.
The technician and the three students were monitored for isoflurane exposure during the
entire procedure. The concentration for the field blank was below the limit of detection of
0.04 ppm.
Drug Pump Implantation in Mice
A technician implanted drug release mini-pumps into three mice. Anesthesia was
induced using 2% isoflurane at a flow rate of 1 L/min a clip top induction chamber. The
mouse was removed from the chamber, shaved, and placed on a nose cone to maintain
anesthesia at 2% isoflurane at 1 a flow rate of L/min.
The technician implanted the mini-pump device in the abdomen of the animal.
The technician repeated the procedure for two more mice. Animals were covered the
cages and returned to housing. Mice were housed in the procedure room. Two vapor
guard passive canisters were used to scavenge waste gas. One canister was attached
to the induction chamber and one was attached to the nose cone. A BSC was available
in the room but not used during the procedure. No vacuum scavenging lines were
available for the room. The technician was monitored for the entire procedure time of 34
minutes.
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The isoflurane concentration for the field blank was below the limit of detection of
0.04 ppm.
Heart Ultrasound in Mice
Six mice were used in this study. Two researchers participated in the study, a
technician who ran the ultrasound machine, and a second researcher who assisted the
technician. Both researchers were monitored for isoflurane exposure during the entire
procedure.
The mice were anesthetized using 3% isoflurane at a flow rate of 1 L/min in a clip
top induction chamber on the bench top. Anesthesia was maintained with the nose cone
attached to the ultrasound machine at 1% at a flow rate of 1 L/min. Each animal was
anesthetized individually. Once under anesthesia, the animal was moved to the
ultrasound stage and secured using tape. A large dollop of ultrasound gel was placed on
the mouse’s abdomen. The transducer was lowered and positioned manually by the
technician. The heart was imaged and recorded by the technician. The entire procedure
for all six animals took 70 minutes to complete. After the procedure, the researchers
cleaned the room and returned the mice to the housing facility.
Two F/Air canisters were used to scavenge waste anesthetic gas. One F/Air
canister was attached to the induction chamber; the second was attached to the
ultrasound nose cone. No active vacuum ports were observed in the room. The
researchers worked with the door to the room open to the hallway. The isoflurane
concentration for the field blank was below the limit of detection of 0.04 ppm.
Humanization Liver Model in Mice
Two researchers completed a procedure to create humanized mouse liver
models in four mice. Anesthesia was induced using a slide top induction box outside of a
BSC. A technician shaved mice and placed them in the induction chamber. Mice were
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individually induced at 4% isoflurane at a flow rate of 1 L/min by the technician. The mice
were transferred to a class 2 BSC for the procedure.
Anesthesia was maintained at 2% isoflurane at a flow rate of 1 L/min on nose
cones. The researcher transferred human hepatocyte cells into the mouse spleen.
Hepatocyte cells were aspirated into a specialized needle/loop apparatus and
transferred to the mouse. While conducting the procedure the sash of the BSC was
raised above the maximum height. The researcher ignored the alarm and turned the
alarm off several times. The researcher also leaned into the BSC so that the researchers
head and shoulders were inside of the BSC while working.
Two F/Air canisters were used to scavenge waste anesthetic gas. One was
attached to the induction chamber outside of the BSC and one was attached to the nose
cone inside of the BSC. The technician and researcher were monitored for isoflurane
during the entire procedure. The total procedure time took approximately 1 hour,
including cleanup. The isoflurane exposure for the field blank was less than 0.17.
Kidney Ultrasound in Mice
One researcher performed the ultrasound on the kidneys of 8 mice. Mice were
anesthetized individually in a clip top induction chamber using 2.5—5% isoflurane at a
flow rate of 1 L/min for approximately 1 minute. The mice were removed from the
chamber and placed on the ultrasound stage and secured using tape. Anesthesia was
maintained by delivering 2% isoflurane at a flow rate of 1 L/min to the nose cone of the
ultrasound machine.
The researcher removed the hair from the abdomen of the mouse and applied
ultrasound gel to the abdomen. The researcher then manipulated the ultrasound
transducer to image the kidney and related blood vessels. After imaging the animal was
placed back in the cage to recover. The procedure was repeated for 8 mice and took
place for approximately 2 hours. After the procedure the researcher cleaned up and took
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the mice back to the housing area. The isoflurane concentration for the field blank was
below the limit of detection of 0.04 ppm.
MRI Imaging in Mouse
Two researchers imaged a mouse using a small animal MRI. The mouse was
anesthetized using 1.5% isoflurane at a flow rate of 1 L/min in a slide top induction
chamber. The induction chamber was attached to an active vacuum line to scavenge
waste anesthetic gas from the top of the chamber. The mouse was in the induction
chamber for 20 minutes.
After the mouse was anesthetized, the student researcher placed the mouse in
an MRI chamber of the bench top. The chamber with the mouse was then placed in the
MRI. The student researcher and technician adjusted the MRI for the procedure. The
MRI procedure and animal’s vitals were monitored using a computer approximately 4
feet from the MRI. Anesthesia was maintained at 1.5% at a flow rate of 1 L/min using a
nose cone within the MRI. The animal was imaged for approximately 2 hours, recovered,
and taken back to its housing area. The technician and student researcher were
monitored for isoflurane exposure during the entire procedure except when placing the
animal in the MRI and adjusting the MRI. The researchers could not be monitored during
this time due to the metal clips on the passive monitoring badges. This time was
approximately 10 minutes of the entire procedure. The isoflurane concentration for the
field blank was below the limit of detection of 0.04 ppm.
Skin Disease Model in Mice
A research student performed skin test procedures on 20 mice. Anesthesia was
induced at 3% isoflurane at a flow rate of 1 L/min in a slide top induction chamber placed
within a class 2 BSC. After 5 minutes the isoflurane concentration was reduced to 1.5%.
Mice were anesthetized 5 at a time.
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After induction, mice were removed from the induction chamber and anesthesia
was maintained on nose cone inside of BSC. A total of 5 nose cones were setup for the
procedure. The researcher applied cream to the ears of the mice using a small spatula.
The mice were kept under anesthesia for 30 minutes. Mice were rotated on the nose
cones. A maximum of 10 mice were under anesthesia at a time; five mice in the
induction chamber and five mice on nose cones. Mice were recovered in cages. The
researcher cleaned up the room and placed the animals in the housing area. The
isoflurane concentration for field blank was below 0.17 ppm.
Time Course Model in Mice
Two researchers completed a tail vein injection and euthanasia/ dissection of five
mice. A large induction chamber was placed in a class 2 A2 BSC. The induction
chamber was flooded with 5% isoflurane at a flow rate of 3 L/min for approximately 5
minutes. The isoflurane concentration was reduced to 2.5% at a flow rate of 3 L/min and
all five mice were placed in the induction chamber to induce anesthesia.
One researcher placed mice in and removed mice from the induction chamber.
This researcher also injected the tail veins of the mice. A technician prepped the tail vein
injections. Two mice were euthanized and dissected immediately after the tail vein
injection. Mice were euthanized on the bench top CO2 euthanasia station, which is a
specially designed cage lid which fits tightly over the mouse cage and pumps CO2 into
the cage. The technician immediately dissected the euthanized animals and collected
tissues in a second BSC. The other three mice were euthanized and dissected in the
laboratory at two and four hours after tail vein injection; by the researcher. The tail vein
injection and two dissections were completed in the same room in approximately 1 hour.
The researchers cleaned up and took the remaining three mice to the lab for holding.
A ReFresh canister was attached to the induction chamber and placed in the hood to
scavenge waste gas. The vaporizer was flushed with O2 before being turned off. Both
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researchers were monitored for isoflurane exposure during the tail vein injections, the
first two dissections, and cleanup from the procedure. Researchers were not monitored
in the lab for isoflurane exposure as isoflurane use was completed for the day and the
researchers were leaving the procedure room in which isoflurane was used. The
isoflurane concentration for the field blank was below 0.35 ppm.

